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ABSTRACT OF THE DISSERTATION  
Development of Enteric Neurons and Muscularis Macrophages. 
by  
Marina Avetisyan 
Doctor of Philosophy in Biology and Biomedical Sciences  
Neurosciences  
Washington University in St. Louis, 2019 
Professor Robert O. Heuckeroth, Chair  
Professor Aaron DiAntonio, Co-Chair 
 
The enteric nervous system (ENS) is a complex interconnected network of neurons and 
glia in the bowel wall that regulates intestinal motility, blood flow, and epithelial function. The 
ENS also controls aspects of inflammatory signaling within the bowel. To perform these tasks, 
there are at least 20 types of enteric neuron and four types of enteric glia.  Although much is 
known about early events in ENS development, signals governing the development of specific 
neuronal subtypes and communication with neighboring cell types within the bowel remain 
poorly understood. One fundamental hypothesis is that diverse trophic factors support distinct 
neuronal populations in the bowel. 
Based on our observations that the hepatocyte growth factor (HGF) receptor Met is 
expressed in all ENS precursors and in a subset of adult enteric neurons, we investigated the role 
of HGF and MET in the ENS.  We found that mice lacking functional MET receptor in the ENS 
(Met cKO mice) exhibit defects in a subset of CGRP-expressing sensory neurons in the 
myenteric plexus.  These sensory cells, known as intrinsic primary afferent neurons (IPANs), are 
responsible for transmitting signals such as bowel stretch and villus deformation from the bowel 
xii 
 
lumen to other myenteric neurons. Met cKO mice have altered CGRP-IR neurite patterning with 
a corresponding failure to trigger peristalsis in response to villus stroking, but a normal response 
to bowel stretch.  This work suggests that MET is important for the development and function of 
a subset of IPANs the bowel.  
HGF has also been known for more than a decade to protect the bowel from injury in 
colitis models.  It had been assumed that HGF’s protective effects were mediated by MET 
present on bowel epithelial cells.  Using Met cKO mice that are missing MET in the ENS, but 
have normal MET in gut epithelium, we showed that neuronal HGF signaling contributes to the 
protective effects of HGF in the bowel that have been previously reported. Met cKO mice have 
significantly more bowel injury following treatment with dextran sodium sulfate (DSS) to induce 
colitis. Furthermore, these animals show reduced proliferation of epithelial cells in the context of 
injury. Together these findings suggest that that HGF/MET signaling is important for 
development and function of a subset IPANs and that these cells regulate intestinal motility and 
epithelial cell proliferation in response to bowel injury. 
Our studies of Met cKO mice highlighted how defects in neurite patterning of enteric 
neurons can profoundly affect bowel function.  Surprisingly little is known about factors that 
govern appropriate formation of neuronal connections in the bowel. To identify other cues 
important for enteric neuron axon patterning, we used broad microarray gene expression 
profiling.  Gene expression in embryonic day 17.5 (E17.5) ENS cells was compared to gene 
expression in surrounding cells to identify genes encoding cell surface receptors or adhesion 
molecules enriched in the ENS that have known roles in axon pathfinding. We found that the 
semaphorin receptor Plexin-A4 was highly enriched in the ENS and confirmed this by in situ 
hybridization (ISH) at E17.5.  Immunohistochemistry using a commercial antibody to Plexin-A4 
xiii 
 
suggested that Plexin-A4 was found in a subset of calretinin-IR neurons.  However, staining of 
Plexin A4 knockout (Plexin A4 KO) bowel revealed this antibody to be non-specific. Despite 
testing two other Plexin-A4 antibodies, we were unable to determine which enteric neurons 
produce Plexin A4.  We analyzed the ENS of Plexin A4 knockout (Plexin A4 KO) mice but 
could not identify any gross defects in neurite patterning. Additionally, functional analysis of 
Plexin A4 KO mice did not reveal any defects in the peristaltic reflex of these animals. As is true 
for other parts of the nervous system, it is likely that Plexin A4 acts redundantly with Plexin A2 
(also enriched in the ENS) and any effects on axon pathfinding in the ENS would only be 
revealed in Plexin A4/Plexin A2 double knockout mice.   
 Remarkably, the non-specific Plexin A4 antibody we had been using also labeled a 
population of poorly characterized muscularis macrophages within the bowel muscularis externa, 
and we decided to study these cells. Bowel macrophages integrate a variety of environmental 
stimuli to assume either a pro-inflammatory or tissue-protective phenotype.  A growing body of 
evidence suggests that neuronal cholinergic and noradrenergic signaling dampens the 
inflammatory phenotype of muscularis macrophages found in close contact with enteric neurons. 
Additionally, it’s been suggested that enteric neurons produce CSF1, the main survival factor for 
muscularis macrophages. This would imply that these macrophages would be abnormal when the 
ENS is missing.  Surprisingly, we found that muscularis macrophage colonization of the bowel 
precedes colonization by enteric neurons and that the main source of CSF1 during development 
is non-neuronal. Furthermore, Ret knockout mice that are completely missing enteric neurons in 
the small bowel and colon contain normal numbers of well patterned macrophages. Additionally, 
these macrophages do not differ in their expression of activating cell surface markers, or in their 
ex-vivo response to lipopolysaccharide (LPS) stimulation. These studies help clarify the role of 
xiv 
 
ENS in the homeostasis and activation of muscularis macrophages, suggesting that, at least 
developmentally, enteric neurons are dispensable for muscularis macrophage survival and do not 
alter the baseline inflammatory status of muscularis macrophages.  
1 
 
Chapter 1: Introduction 
The enteric nervous system is the largest and most complex division of the peripheral and 
autonomic nervous system in vertebrates (Lake & Heuckeroth 2013; Obermayr et al. 2013). It 
contains various types of neurons and glia in numbers comparable to that found in the spinal 
cord, and an array of neurotransmitters similar to that seen in the central nervous system (CNS) 
(Obermayr et al. 2013). Such a complex array of cells and signals is necessary to mediate the 
many bowel functions controlled by the ENS. These functions include regulating motility, 
secretion, and blood flow. In addition, the ENS has also been recently implicated as a major 
regulator of immune signaling in the bowel. This occurs in part through communication with 
muscularis macrophages (Matteoli et al. 2014; Muller et al. 2014; Gabanyi et al. 2016). The 
work in this dissertation deals with several distinct aspects of enteric neuron development, and 
the impact that enteric neurons have on developing muscularis macrophages.  
In Chapter 2, I review the stages of ENS development, beginning with delamination of 
neural crest cells and ending with functional neural circuit formation in the bowel. I also discuss 
various pathologies that arise as a result of disturbances in ENS development.  
In Chapter 3, I define the role of hepatocyte growth factor (HGF) and its receptor MET in 
the development and function of a set of sensory neurons in the bowel. I demonstrate that mice 
lacking functional MET in the ENS have defects in MET-positive neurite formation, the 
peristaltic reflex, and epithelial repair in response to injury.  
In Chapter 4, I describe our efforts to use gene expression profiling to identify axon 
guidance molecules with potential roles in wiring the ENS. Using this approach we determined 
that the classic semaphorin guidance cue receptor, Plexin A4 was highly enriched in the ENS. I 
2 
 
also describe our findings that the ENS of Plexin A4 KO mice appears grossly normal, and that 
these mice do not have defects in peristalsis.  
In Chapter 5, I demonstrate that enteric neurons are dispensable for the development of 
neonatal muscularis macrophages. I also provide evidence that mechanisms governing the 
maintenance of muscularis macrophages in the steady state adult bowel differ from those 
regulating other macrophage populations in the bowel.   
In Chapter 6, I discuss the implications of my work and propose future directions.  
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Chapter 2: Building a Second Brain in the 
Bowel 
 
Marina Avetisyan,* Ellen Merrick Schill,* and Robert O. Heuckeroth 
*These authors contributed equally to this work. 
This review was published in The Journal of Clinical Investigation 2015 Mar 2;125(3):899-907. 
It is reprinted here with permission. 
2.1 Abstract 
The enteric nervous system (ENS) is sometimes called “The Second Brain” because of 
the diversity of neuronal cell types and complex integrated circuits that permit the ENS to 
autonomously regulate many processes in the bowel.  Mechanisms supporting ENS development 
are intricate with numerous proteins, small molecules, and nutrients that impact ENS 
morphogenesis and mature function. Damage to the ENS or developmental defects cause 
vomiting, abdominal pain, constipation, growth failure and early death.  Here we review 
molecular mechanisms and cellular processes that govern ENS development, identify areas 
where more investigation is needed, and discuss clinical implications of new basic research. 
2.2 Introduction  
Survival requires elegantly integrated mechanisms that control bowel motility, secretion, 
and blood flow to permit fluid and nutrient absorption and support waste elimination.  If control 
of bowel function required conscious thought, there might be little else that we could do in life.  
Fortunately, the enteric nervous system (ENS) controls most aspects of bowel function (1, 2). 
The ENS is a complex network of neurons and glia that resides in the myenteric and submucosal 
plexus of the bowel.  The myenteric plexus, located between longitudinal and circular muscle, 
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primarily controls muscle contraction and relaxation. The submucosal plexus, found between 
circular muscle and bowel mucosa, regulates fluid secretion and absorption, modulates blood 
flow, and responds to stimuli from epithelium and lumen to support bowel function. 
 In most people, the ENS works well, making it easy to forget that the bowel needs its 
own nervous system.  However, ENS defects may underlie common problems like irritable 
bowel syndrome (IBS) (3) and less common problems like Hirschsprung disease (HSCR) (4, 5), 
chronic intestinal pseudoobstruction syndrome (CIPO) (6), or gastroparesis (7). HSCR is a life-
threatening birth defect where the ENS is completely missing from distal bowel.  In CIPO or 
gastroparesis, the ENS or other bowel cells are defective causing dysmotility, pain and difficulty 
maintaining enteral nutrition. In IBS, altered bowel motility and sensory responses cause pain 
accompanied by diarrhea or constipation, but health is not otherwise affected.  ENS defects also 
occur in Parkinson’s (8), diabetes (9), or inflammatory bowel disease (IBD) (10) and recent data 
suggest that ENS damage might play an early etiologic role in IBD (11, 12) and Parkinson’s (13-
15).  Here we focus on cellular and molecular mechanisms controlling ENS development, 
highlighting areas that require further investigation and potential clinical implications of new 
discoveries. 
 
2.3 ENS morphogenesis 
 
 The ENS forms from enteric neural crest-derived cells (ENCDC) that delaminate 
primarily from vagal neural tube with smaller contributions from sacral and upper thoracic 
neural tube (2, 16-18).  Vagal ENCDC migrate through paraxial mesoderm before entering 
bowel and then migrate in a rostral to caudal direction to colonize the entire fetal bowel (Figure 
2.1A).  Vigorous ENCDC proliferation during migration is important for full bowel colonization 
(19, 20).  ENCDC differentiate into at least 20 neuronal subtypes or enteric glia (21), form 
ganglia, extend neurites, and establish and refine functional neural circuits to control the bowel 
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(22) (Figure 2.1B). A subset of ENCDC undergoes radial migration either inward to form the 
submucosal plexus or out of the bowel to form ganglia in the pancreas.  These complex 
processes require transcription factors, cell surface adhesion molecules, receptors, extracellular 
ligands, cytoskeletal rearrangements and diverse intracellular signaling molecules summarized in 
excellent recent reviews (1, 2, 16, 23-25).   
 
2.4 Retinoids, RET, and bowel colonization 
 Migrating ENCDC are surrounded by regulatory molecules that guide development.  One 
early critical interaction occurs as ENCDC migrate through paraxial mesoderm before invading 
foregut (E8.5 in mice, E2.5-3 in quail) (17, 26). During this transition, ENCDC begin to express 
RET in response to local retinoic acid (RA) synthesis by paraxial mesoderm (17) (Figure 2.2A). 
This is important because RET supports ENCDC survival, proliferation and migration (2, 27-33), 
and homozygous Ret inactivation prevents ENCDC from colonizing bowel distal to the stomach 
(34, 35).  Exogenous RA can substitute for an otherwise essential paraxial mesoderm interaction 
in quail to induce RET (17).  Mice deficient in retinaldehyde dehydrogenase 2 (RALDH2), an 
enzyme that makes RA, also fail to express Ret and have total intestinal aganglionosis (36). 
 RET is the signaling receptor for glial cell line-derived neurotrophic factor (GDNF), 
neurturin (NRTN), artemin (ARTN) and persephin (PSPN) (37), ligands that bind preferentially 
to the co-receptors GFRA1, GFRA2, GFRA3, and GFRA4 respectively (38).  GFRA1 and RET 
are co-expressed by migrating ENCDC, but GFRA1 is also produced by surrounding gut 
mesenchyme along with GDNF (39, 40).  Like RET, GDNF and GFRA1 are required for 
ENCDC survival, proliferation and migration. Homozygous mutations in Ret, Gdnf or Gfra1  
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Figure 2.1 
 
Figure 2.1. ENS Morphogenesis.   
(A) Vagal ENCDC migrate in a rostral to caudal direction through fetal bowel (long white 
arrow).  At E12.5 ENS precursors have migrated half way through fetal colon.  ANNA-1 
antibody binds HuC/D antigen and identifies enteric neurons (magenta cells) while TuJ1 binds 
neuron specific beta III tubulin and labels neurites (green).  ENCDC migrate in chains though the 
bowel, but during the period of migration some precursors differentiate into neurons and extend 
neurites including at the migration wavefront (white arrows).  (B) Adult small bowel myenteric 
plexus shown by ANNA-1 antibody (red neurons), SOX10 antibody (green enteric glia), and 
TuJ1 antibody (blue) demonstrates clusters of neurons and glia in mature ganglia as well as 
many neurites within and between ganglia.  Scale bars = 100 microns. 
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Figure 2.2 
 
Figure 2.2 ENS 
Development.  
 (A) Murine vagal neural crest 
cells destined for the ENS 
delaminate from the neural 
tube at E8.5.  These ENCDC 
are exposed to RA as they 
migrate by paraxial mesoderm 
on their way to the foregut at 
E9.  (B) Once ENCDCs are in 
developing bowel, efficient 
caudal migration relies on 
vigorous ENCDC proliferation 
(top panel) as disorders that 
reduce ENCDC proliferation 
(bottom panel) commonly 
cause incomplete bowel 
colonization. (C) Efficient 
ENCDC migration is 
facilitated by contact between 
migrating cells.  Chain 
migration of ENCDCs is 
quicker and more directed than 
migration of isolated ENCDC.  
Disorders that alter ENCDC 
cell adhesion also delay bowel 
colonization and may cause 
HSCR.  (D) After ENCDCs 
have populated the whole 
developing bowel (E13.5 in 
mice) in the region of the 
future myenteric plexus, a subset of ENCDC migrates inward radially to form the submucosal 
plexus.  Radial migration is regulated by RET-GDNF signaling axis and by Netrin/DCC 
chemoattraction.  (E) nNOS-IR DG I neurons send caudal projections in the longitudinal axis, 
whereas CGRP-IR DG II neurons project circumferentially. Both DG I and DG II neurons are 
present at P0. However, only DGII neurons exhibit mature lamellar dendrites at this age, whereas 
most DG I dendrites are still filamentous. The proportion of DG I lamellar dendrites increases 
from P0-P10. DG II projections do not grow in length from P0-P10, whereas DG I projections 
do, though their growth rate does not match that of the bowel.  There is significant maturation of 
the ENS after birth, at least in rodents. 
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cause indistinguishable ENS phenotypes in mice (34, 39, 41-44). RET mutations are also very 
common in people with HSCR (2, 16, 23, 45, 46).   
   
2.5 Cell proliferation and bowel colonization 
 One long-standing mystery is why ENCDC colonize the entire fetal bowel since 
individual ENCDC appear to thrive anywhere along the bowel. The absence of essential intrinsic 
guidance cues for rostrocaudal migration is likely since ENCDC migrate in either direction 
through aganglionic bowel (47-49) and bypass a cecal zone with high concentrations of the 
chemoattractant GDNF (47).  Theoretical modeling suggests that rostrocaudal bowel 
colonization is driven by ENCDC proliferation that causes competition for space and trophic 
factor (19) (Figure 2.2B).  In vitro and in ovo data support this idea since reduced ENCDC 
proliferation or cell number may cause incomplete bowel colonization.  For example, removal of 
vagal neural tube segments where ENCDC originate causes distal intestinal aganglionosis (50, 
51). RET mutations that reduce ENCDC proliferation or enhance cell death also cause bowel 
aganglionosis (27, 28), as does treatment with mycophenolic acid, an inhibitor of guanine 
nucleotide synthesis that reduces ENCDC proliferation, but does not prevent ENCDC from 
migrating at appropriate doses (20). Finally, mutations in endothelin receptor B (EDNRB) or its 
ligand endothelin-3 (EDN3) cause premature differentiation and cell cycle exit (52-54) leading to 
HSCR in humans and distal bowel aganglionosis in mice (55, 56). Interestingly, Ednrb and Edn3 
deficient ENCDC can colonize distal bowel normally if accompanied by adequate numbers of 
WT ENCDC, proving they are able to migrate into distal bowel (57, 58).  One corollary to the 
hypothesis that competition for “space” drives ENCDC migration is that ENCDC must be 
restricted to specific layers of the bowel.  In part, sonic hedgehog from gut epithelium restricts 
ENCDC to the outer bowel wall during migration (59), but the mechanism underlying this 
observation is not understood. 
 
2.6 Chain Migration and Cell Adhesion 
 Bowel colonization by ENCDC is enhanced by “chain migration”, a process where 
ENCDC preferentially contact each other while migrating (60, 61) (Figure 2.2C).  The 
importance of ENCDC cell-cell contact is suggested by human L1 cell adhesion molecule 
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(L1CAM) mutations that increase risk of HSCR, hydrocephalus and corpus callosum defects (62-
64). L1cam mutations also increase “unattached” ENCDC and reduce bowel colonization in mice 
(62).  Ex vivo imaging shows that ENCDCs in chains migrate more quickly through bowel and 
with more directional persistence than isolated ENCDC (48).  We do not, however, understand 
why contact between ENCDC enhances bowel colonization.  One hypothesis is that cells at the 
front of the migrating ENCDC chain “pull” trailing ENCDC via L1CAM-mediated adhesion.  
This seems unlikely since migrating ENCDC constantly change position moving over each other 
(47, 48).  Another possibility is that ENCDC enhance bowel colonization by altering 
extracellular matrix (ECM) to enhance migration (65) or by degrading ECM to create spaces to 
migrate through.  Consistent with this latter hypothesis, matrix metalloproteinase-2 (MMP2) 
inhibition slows ENCDC migration (66). Preferential ENCDC migration along neurites (48, 67) 
might also help cells navigate gut mesenchyme to preexisting gaps in the ECM. These 
hypotheses could explain why chain migration is more efficient than “isolated” ENCDC 
migration. Alternatively, isolated ENCDC may simply be “happy” to stay where they are since 
there is no competition for space or trophic factors, an idea espoused in the previous section.  In 
either case, defining mechanisms supporting chain migration may provide new insight into 
human bowel motility disorders.  
 
2.7 Intracellular signaling and Migration  
 Complex intracellular signaling controls cytoskeletal rearrangements and focal adhesions 
essential for ENCDC migration.  Mechanisms must be dynamically regulated because cells at the 
ENCDC migration wavefront behave differently from cells behind the “wavefront”.  Recent 
elegant Förster resonance energy transfer (FRET) studies confirm that PKA, RAC1, and CDC42 
are differentially activated in migrating ENCDC depending on proximity to the wavefront (68).  
These proteins regulate the mode of cell migration (69, 70), and the efficiency of bowel 
colonization.  Interestingly, both PKA inhibition and exogenous cAMP analogs slow ENCDC 
migration in organ culture (68, 71), but critical PKA targets in this context are not known.  This 
suggests that localized PKA activation or moderate activation is needed to support migration.  
One possible PKA target is RET, which is phosphorylated and activated to enhance migration 
(71).  RET in turn activates many molecules including RAC1 (72-74), which orchestrates 
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cytoskeletal rearrangements to induce lamellipodia in cells migrating across two-dimensional 
substrates (75).  RAC inhibition slows ENCDC migration in vitro and in ex vivo organ culture 
(68, 73, 76). Elevated RHOA, which often acts in opposition to RAC, also disrupts ENCDC 
chain migration and causes hypoganglionosis (77). Curiously, inhibition of ROCK, an effector of 
RHOA, enhances ENCDC migration in vitro on collagen, but reduces ENCDC migration 
through bowel in organ culture (76).  These apparently conflicting data suggest that in vitro 
results may not mimic mechanisms needed for migration through the bowel in vivo because 
different migration modes are optimal for different contexts.  Evaluating mechanisms of ENCDC 
migration in “natural” three dimensional environments like bowel wall may therefore provide 
new insight into how medicines, toxins, genetics, or disease affect the developing ENS. 
 Additional complexity arises because signaling molecules may have different roles in 
different developmental contexts.  For example, RA from paraxial mesoderm induces RET in 
neural crest cells (NCCs) migrating from the neural tube to the foregut (17).  In contrast, when 
ENCDC have almost fully colonized the embryonic mouse bowel (E12.5), RET levels do not 
appear altered by retinoic acid receptor (RAR) antagonists (74, 78).  Instead, in distal bowel RA 
reduces phosphatase and tensin homolog (PTEN) in ENCDC at the migration wavefront to 
support migration.  PTEN dephosphorylates phosphatidylinositol-3 phosphate (PIP3), a lipid that 
activates AKT and other proteins that, together with downstream effectors, orchestrate 
cytoskeletal rearrangements needed for migration, and promotes survival and proliferation (74).  
Interestingly, PTEN levels increase in ENCDC behind the migration wavefront despite the 
presence of RA and this increase in PTEN protein supports neuronal differentiation. RA also 
decreases SMURF1 ubiquitin ligase expression in axon tips of enteric neurons to reduce neurite 
growth (78).  This appears to be a unique adaptation of developing enteric neurons that may 
facilitate migration.  Thus, several RA regulated genes play critical roles in ENS development, 
but effects of RA are context dependent. Care is needed when evaluating protein function to 
consider the developmental context since the role of many proteins (e.g., RET, BMP4, Notch, 
Hand2, Shh) changes depending on developmental stage, concentration, and cellular target (2, 
16, 23-25). 
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2.8 ENS morphogenesis does not end when ENCDC reach 
“The End” 
 
 During rostrocaudal bowel colonization in mice, ENCDC migrate in the location of the 
future myenteric plexus, an area rich in GDNF (79). Beginning at E14.5, some ENCDC migrate 
inward (“radial migration”) to form the submucosal plexus, while at earlier stages other ENCDC 
migrate into the pancreas to form ganglia near the Islets of Langerhans (23, 79, 80) (Figure 
2.2D). Radial migration inward to the submucosal plexus and outward toward the pancreas is 
regulated by the chemoattractant netrin, which is secreted by fetal gut epithelium and pancreas, 
and binds the receptor Deleted in Colon Cancer (DCC), expressed by a subset of ENCDC (79).  
Cells that move to the submucosal plexus also have less RET signaling than adjacent ENCDC 
(80).  During radial migration, peri-muscular gut mesenchyme down-regulates Gdnf and 
mesenchyme closer to the lumen up-regulates Gdnf (80). This change in GDNF localization 
provides additional stimulus for ENCDC with low RET activity to migrate inward.  How cells 
modulate levels of RET and how neighboring cells communicate to ensure that only a subset of 
cells leave the myenteric plexus is unknown.    
 As rostrocaudal migration nears completion, ENCDC aggregate to become ganglia.  
Differential adhesion is important (81) and mediated at least in part by neural cell adhesion 
molecule 1 (NCAM1) (82, 83).  Polysialic acid (PSA) addition to NCAM1 in response to 
mesenchyme-derived bone morphogenetic protein 4 (BMP4) further promotes aggregation and 
reduces ENCDC migration. PSA-NCAM1 is not abundant in ENCDC until gangliogenesis 
begins and blocking PSA addition reduces ganglia formation (83).  Some migratory ability is 
necessary for ganglia organization and may explain why mice lacking 1 integrin, a receptor 
that binds ECM, have disorganized ganglia (84, 85).  A more severe defect occurs in mice with 
conditional inactivation of the transcription factor Hand2 in ENCDC where myenteric ganglia 
fail to form completely (86). Hand2 mutations reduce NCAM1, among many other defects. For 
example, HAND2 is needed for terminal differentiation of enteric neurons (12, 87, 88) and this 
more global effect on neurogenesis may underlie the effect of Hand2 mutations on ganglion 
formation and bowel motility.  Additional work is needed to identify HAND2 targets and to 
define mechanisms controlling enteric ganglia formation. 
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2.9 Neuronal subtype specification 
 Enteric ganglia contain at least 20 distinct neuronal subtypes that differ in function, 
transmitters, neurite patterning and electrophysiology (21). Undoubtedly diverse trophic factors, 
morphogens, and transcriptional regulators influence enteric neuron subtype specification 
(summarized in Table 2.1), supporting lineage commitment and selective cell proliferation. 
However, mechanisms determining enteric neuron subtype are barely understood and a genetic 
blueprint for specifying a single type of enteric neuron does not yet exist. Birth-dating studies 
show that progenitors for neuronal subtypes exit the cell cycle at different times throughout 
development (89-91).  The observation that factors influencing ENCDC proliferation (e.g., 
GDNF) or differentiation (BMPs) may alter the ratio of enteric neuron subtypes within the bowel 
in a way that depends on “birth date” suggests genetically programmed lineage commitment tied 
to the timing of cell cycle exit (28, 32, 92, 93).  Cell fate, however, is determined by a 
combination of extrinsic signals from a cell’s microenvironment and the intrinsic transcriptional 
programming that renders the cell competent to selectively respond to some extracellular signals. 
It is assumed that over time pluripotency of enteric neural precursors becomes increasingly 
restricted, resulting in greater lineage commitment. Reconstructing lineage relationships among 
enteric neuron subtypes, however, or defining events that restrict cell lineage is challenging with 
currently available data. Figure 2.3 provides one model for enteric neuron subtype lineage 
relationships reflecting recent data about transiently catecholaminergic (TC) cells. TC ENS 
precursors arise early in development (89) and absolutely require the transcription factor 
ASCL1/MASH1 (94). Serotonergic neurons, but not other subtypes, also require 
ASCL1/MASH1 and were thought to arise exclusively from TC precursors.  Fate mapping 
studies of tyrosine hydroxylase expressing cells now suggest that TC precursors give rise to only 
30% of serotonergic neurons, but also can become calbindin, calretinin, and neurofilament-M 
expressing neurons (95). Importantly, TC-precursors give rise to less than 3% of myenteric 
neurons and 13% of submucosal neurons in the mouse distal small intestine. It is unclear if TC 
precursor-derived serotonergic neurons differ from non-TC-derived serotonergic neurons. The 
complexity of these data highlights how little we understand enteric neuron subtype 
specification.          
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Table 2.1. Neuronal subtype specification.  Changes in expression levels for these proteins have been shown to alter the abundance of specific 
subtypes of enteric neurons in vivo. 
Molecule Experimental 
Manipulation 
Effect on Enteric Neuron Subtypes References 
GDNF (glial cell derived neurotrophic 
factor) 
Over-expression in late 
development (E17) 
under glial GFAP 
promoter 
Increased nNOS-IR neuron number 
No change in ChAT neuron number 
(32) 
RET 1. Ret-/- 
 
2. Conditional loss of Ret 
plus rescue by Bcl-xL 
expression 
1.  More dramatic loss of NOS neurons than 
other neurons in esophagus 
2.  Striking loss of NOS neurons in colon 
 
 
(93) 
 
(28) 
BMP Over expression of 
BMP4 under neuronal 
NSE promoter 
1. Increased TrkC-IR, NT3-IR, 
nNOS-IR neurons 
(90) 
NT3 (neurotrophin 3) Loss of NT3 or the NT3 
receptor, TrkC  
1. Decreased neuron number. 
2. Preferential decrease in 
submucosal CGRP-IR neurons 
(132) 
NT3  Over expression of NT3 
under dopaminergic 
DBH promoter 
Increase in neuronal number (132) 
EDN3 (endothelin 3) Loss of the EDN3 or 
receptor, EDNRB  
1. Increased proportion of nNOS-IR 
and VIP-IR neurons 
2. Decreased proportion of ChAT-IR 
neurons 
3. Region specific changes in 
proportion of Substance P-IR, 
NPY-IR, galanin-IR, PACAP-IR 
and VIP-IR neurons 
(133, 
134) 
Ascl1/Mash1 Loss of Ascl1/Mash1 1. Decreased neuron number 
2. Reduced esophageal neuron 
number 
3. Loss of transiently 
catecholaminergic neurons 
4. Loss of 5HT-IR neurons 
(94, 
135) 
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Hand2 Loss of Hand2 Loss of or reduced nNOS/VIP-IR, reduced 
ChAT-IR, calretinin-IR, DAT-IR neurons  
(86, 88) 
5HT (5- hydroxytryptophan/serotonin) Loss of neuronal 5-HT 
synthesizing enzyme 
TPH2 
Decreased GABA-IR, DAT-IR neurons (97) 
NET (norepinephrine transporter) Loss of NET Decreased 5HT-IR, calretinin-IR neurons (98) 
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Figure 2.3 
 
 
Figure 2.3 ENS precursor lineage relationships and neuronal subtype specification.  
Lineage relationships among enteric neuron subtypes remain poorly understood.  This figure 
summarizes in vivo observations.  Transcription factors are in italics. Gain of function data are 
indicated in red.  Loss of function data are indicated in blue.  Most myenteric neurons arise from 
TH negative precursors, as indicated by the relative thickness of arrows. 
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One additional critical question is how ratios of enteric neuron subtypes are controlled to 
produce integrated circuits and ganglia with diverse neuron types. If proliferating ENCDC are 
lineage restricted early, establishment of ganglia with multiple neuron subtypes would require 
segregation and organization of committed precursors (96).  An alternative mechanism that could 
support this outcome would be if signals from one neuron affected the phenotype of other 
neurons.  In vivo data support this hypothesis since loss of neuronal serotonin causes selective 
decreases in “late-born” dopaminergic and GABAergic neurons (97).  Additionally, the 
norepinephrine reuptake transporter (NET) supports development of serotonergic and calretinin-
immunoreactive (IR) neurons (98). Neural activity also influences differentiation since hindgut 
explants treated with tetrodotoxin or tetanus toxin have fewer nitrergic neurons, but normal total 
neuron number (99).  In contrast, depolarization of ENS precursors in culture increases tyrosine 
hydroxylase- and vasoactive intestinal peptide (VIP)-expressing neurons, but not nitrergic 
neurons (100). Signals from the ECM might also direct subtype differentiation. Culture of ENS 
precursors on collagen IV leads to more nNOS-IR neurons than growth on laminin or heparin 
sulfate (101).  Mechanisms underlying this observation are not known. 
 Remarkably, enteric neuron subtype plasticity appears to continue after birth, at least in 
rodents, where close proximity of the developing ENS to bowel lumen facilitates diet and 
intestinal microbe-induced changes in neuronal cell fate (102).  In rats, the percentage of ChAT-
IR neurons in colon myenteric plexus increases from P14 to P36, whereas the percentage of 
nNOS-IR neurons increases from P1 to P5, and then remains unchanged to P36 (103) .  These 
ratios can be altered by intraluminal lipids. Rats given daily (P7-P17) colon enemas with the 
short-chain fatty acid butyrate have a larger percentage of myenteric and submucosal nNOS-IR 
and myenteric ChAT-IR neurons than controls at P21 (104).  Butyrate treated rats also had 
increased nitrergic and cholinergic neurotransmission and slowed colonic transit.  Piglets whose 
mothers were fed n-3 polyunsaturated fatty acids during pregnancy and lactation also had 
increased ChAT-IR and decreased VIP-IR neurons in the jejunal submucosal plexus (105). These 
data suggest that maternal dietary factors can affect ENS subtype ratios in offspring during 
pregnancy or via altered breast milk composition.  Thus, neuronal subtype specification appears 
to depend on a combination of intrinsic genetic programming and environmental factors. The 
duration of plasticity is not known, but may underlie some human intestinal motility disorders 
and if better understood might suggest novel treatment strategies. 
17 
 
 
2.10 Axon pathfinding and synaptogenesis: A tangled web of 
neurites  
 
 Enteric neurons must extend processes to communicate with diverse cell types including 
other enteric neurons, interstitial cells of Cajal, smooth muscle, endothelial cells, mucosal 
epithelia, and intestinal glands (21). It is not clear if subtype identity is established before enteric 
neurons innervate targets or what guides axons.  This work is challenging because single enteric 
ganglia contain heterogeneous neuron subtypes and fasciculated fiber tracts have diverse axon 
types.  Nonetheless, axons of different enteric neuron subtypes clearly have stereotypic 
projection patterns.  For example, intracellular dye filling after electrophysiologic recording from 
guinea pig intrinsic primary afferent neurons (IPANs) shows projections circumferentially 
around bowel and then into mucosa (106).  Studies using myotomy and myectomy followed by 
immunohistochemistry demonstrate that excitatory motor neuron axons project rostrally, while 
inhibitory motor neurons project caudally within the longitudinal axis of the myenteric plexus 
before entering circular or longitudinal muscle (106, 107).  Elegant models of enteric neuron 
circuitry now exist based on decades of work (1, 22, 108-110), but mechanisms needed to 
establish these connections remain obscure. 
 A few mouse mutations provide insight into axon guidance mechanisms. Mutations in the 
RET ligand neurturin or its preferred co-receptor GFR 2 reduce substance P-IR, but not VIP-IR, 
fibers innervating bowel circular muscle (111, 112). This phenotype could occur because of 
reduced neurite growth or branching, or might reflect problems with axon targeting to circular 
muscle.  More convincing evidence that RET ligands direct neurite growth comes from mice that 
ectopically express GDNF from enteric glia.  In these animals nitrergic, but not serotonergic or 
cholinergic fibers, redistribute towards the source of GDNF, suggesting a chemoattractive effect 
of GDNF on nitrergic axons (113). It is not known if GDNF-dependent chemoattraction is direct 
or if GDNF induces production of new guidance receptors, rendering nitrergic neurons 
competent to respond to new attractant cues.  Non-neurotrophic factors important for regulating 
ENS connectivity were also recently identified. Elegant analysis showed that mice with 
disruption of planar cell polarity genes Fzd3 and Celsr3 have serious defects in axon pathfinding, 
but these were only seen with DiI or by expressing fluorescent proteins in small numbers of 
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enteric neurons. These data highlight the utility of single cell labeling techniques for identifying 
axon pathfinding defects in the ENS (114). Importantly, Celsr3-/- mice have severe dysmotility, 
increased whole gut transit time, and disorganized colonic migrating motor complexes, but major 
neuronal subtypes are present and enteric neuron number is normal, suggesting that difficult to 
recognize innervation patterning defects may seriously affect bowel motility. 
 After pathfinding, enteric neurons must form appropriate synaptic connections within the 
ENS.  Although spontaneous neural activity and synaptic markers are present at E11.5 (115), 
electrophysiologic maturity is not reached until after birth suggesting ongoing refinement of 
neural networks.  Based on morphology and electrophysiology, mature enteric neurons are 
classified as Dogiel Type I (DG I) or Dogiel Type II (DG II) (116) (Figure 2.2E). DG I neurons 
have a single axon, fast excitatory post-synaptic potentials, somas with lamellar dendrites, and 
include excitatory and inhibitory motor neurons (22). DG II neurons have multiple axon-like 
processes, prominent after-hyperpolarizing potentials, smooth somas without lamellar dendrites, 
and include IPANs. Although both DG I and DG II neurons are present by P0 in mice, most DG 
I neurons possess filamentous instead of lamellar dendritic projections. The proportion of 
neurons with lamellar dendrites increases until adulthood (117). Furthermore, while the length of 
DG II circumferential projections remains constant despite dramatic increases in bowel 
circumference from P0 to adulthood, DG I longitudinal axons continue to grow, though slower 
than the bowel. In contrast, DG I neurons have mature electrophysiologic properties by P10, 
while DG II neuron electrophysiologic properties differ from adults at P10. These studies suggest 
that synaptic development, refinement, and remodeling occur postnatally in growing bowel and 
support the hypothesis that environmental disturbances in early life (infection, psychological 
stress, etc.) could profoundly influence adult bowel motility (118) by altering enteric neuron 
anatomy or subtype specification.  
 
2.11 Clinical implications 
 Mechanisms controlling ENS development and function are complicated. Hundreds of 
genes control precursor survival, proliferation, migration, differentiation, subtype specification, 
polarity, neurite growth, axon pathfinding and synaptogenesis.  Tremendous basic research 
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progress provides new insight, but advances have had little impact on care provided for people 
with motility disorders.  Actionable ideas follow naturally from current data. 
 
1. Vitamin A deficiency, a common global problem (119), might be a preventable cause of some 
birth defects including Hirschsprung disease.  Human studies in high risk populations are needed 
to test this hypothesis.  Note: Vitamin A excess also causes birth defects (120) so high doses 
must be avoided in pregnancy. 
2. Some medicines cause Hirschsprung-like disease in mice (20).  Human epidemiologic studies 
identifying non-genetic risks for Hirschsprung disease may lead to new prevention strategies. 
3.  Current clinical evaluation of the ENS is often limited to “present” or “absent” even when 
manometry suggests enteric neuropathy underlies life threatening dysmotility.  We need to 
evaluate neuronal subtypes and track neurites in biopsies from people with bowel motility 
disorders.  New 3D-visualization approaches make this possible (121, 122).  We also need age 
and region specific control data to know what ENS anatomy should be considered normal (123).  
4.  We need to incorporate “next-generation” genetic analysis into clinical testing for people with 
severe motility disorders. This will permit development of novel individually targeted therapies. 
5.  Post-natal gut-derived neural stem cells can now be harvested from humans, cultured, and 
transplanted into animal models where they partially restore function or improve outcome (124-
130).  This provides new hope that autotransplantation and gene editing can be used to treat 
bowel motility disorders and perhaps other serious medical problems.  More work is needed to 
define how to grow and direct differentiation of these stem cells, although recent studies suggest 
that the gut environment might induce differentiation of many types of functioning enteric 
neurons and that these stem cells can integrate into existing ENS circuitry (131). 
We remain optimistic that as mechanisms controlling bowel motility are better defined, 
new approaches to treatment, prevention, diagnosis and cure will be developed to help people 
with serious bowel motility disorders. 
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3.1 Abstract 
 
Factors providing trophic support to diverse enteric neuron subtypes remain poorly 
understood.  We tested the hypothesis that hepatocyte growth factor (HGF) and the HGF 
receptor MET might support some types of enteric neurons.  HGF and MET are expressed in 
fetal and adult enteric nervous system (ENS).  In vitro, HGF increased enteric neuron 
differentiation and neurite length, but only if vanishingly small amounts (1 pg/mL) of glial cell 
line-derived neurotrophic factor (GDNF) were included in culture media.  HGF effects were 
blocked by phosphatidylinositol-3 kinase (PI3K) inhibitor and by MET blocking antibody.  Both 
of these inhibitors and MEK inhibition reduced neurite length.  In adult mice, MET was 
restricted to a subset of calcitonin gene related peptide (CGRP) immunoreactive (IR) myenteric 
plexus neurons thought to be intrinsic primary afferent neurons (IPANs).  Conditional MET 
kinase domain inactivation (Metfl/fl; Wnt1Cre+) caused a dramatic loss of myenteric plexus 
MET-IR neurites and DiI labeling suggested reduced MET-IR neurite length.  In vitro, Metfl/fl; 
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Wnt1Cre+ mouse bowel had markedly reduced peristalsis in response to mucosal deformation, 
but normal response to radial muscle stretch.  However, whole bowel transit, small bowel transit, 
and colonic bead expulsion, were normal in Metfl/fl; Wnt1Cre+ mice. Finally, Metfl/fl; 
Wnt1Cre+ mice had more bowel injury and reduced epithelial cell proliferation compared to WT 
animals after dextran sodium sulfate (DSS) treatment.  These results suggest that HGF/MET 
signaling is important for development and function of a subset IPANs and that these cells 
regulate intestinal motility and epithelial cell proliferation in response to bowel injury. 
 
3.2 Introduction 
Survival depends on controlled intestinal motility to mix food with digestive enzymes, 
bring nutrients into contact with gut epithelium, eliminate waste, and facilitate fluid reabsorption.  
This requires neuronal networks that sense stretch, villus distortion, and luminal content 
composition, and then alter motility to suit constantly changing conditions.  Fortunately, this 
occurs without conscious thought because the bowel has an intrinsic nervous system called the 
enteric nervous system (ENS) that controls most aspects of intestinal function (Bornstein et al., 
2004; Grundy and Schemann, 2005; Wood, 2008; Furness, 2012; Goldstein et al., 2012; Sasselli 
et al., 2012).  The ENS contains at least 20 neuron subtypes that differ in function, 
neurotransmitters, axonal projections and electrophysiology (Furness, 2006b).  Some signals 
governing ENS development and maintenance are known (Obermayr et al., 2012; Sasselli et al., 
2012; Lake and Heuckeroth, 2013), but it is unclear how diverse neuronal populations are 
established or what factors support most enteric neurons after birth.  Trophic factors that affect 
ENS development, maintenance and function include (GDNF) (Moore et al., 1996; Sanchez et 
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al., 1996; Treanor et al., 1996; Chalazonitis et al., 1998; Hearn et al., 1998; Heuckeroth et al., 
1998), neurturin (Heuckeroth et al., 1998; Heuckeroth et al., 1999), nerve growth factor (NGF) 
(Mulholland et al., 1994), brain derived neurotrophic factor (BDNF) (Grider et al., 1997b; 
Boesmans et al., 2008), ciliary neurotrophic factor (CNTF) (Grider et al., 1997a; Chalazonitis et 
al., 2001; Schafer et al., 2003), and neurotrophin-3 (NT3) (Chalazonitis et al., 1994a; 
Chalazonitis et al., 1998; Chalazonitis et al., 2001).  We hypothesized, that hepatocyte growth 
factor (HGF) and its receptor MET might also be important because HGF supports spinal motor 
neurons (Ebens et al., 1996a), dorsal root ganglion (DRG) subtypes (Maina et al., 1997), retinal 
ganglion cells (Tonges et al., 2011), and hippocampal neurons (Lim and Walikonis, 2008). Our 
prior studies also suggested HGF expression in the ENS (Vohra et al., 2006).  Finally, we were 
intrigued by the protective effect of HGF in rodent colitis models (Tahara et al., 2003; 
Mukoyama et al., 2005; Numata et al., 2005; Oh et al., 2005; Hanawa et al., 2006; Kanbe et al., 
2006), and hypothesized this might be mediated through MET expressing enteric neurons. 
 We now demonstrate MET immunoreactivity in most ENS precursors and in a subset of 
adult calcitonin gene related peptide (CGRP) expressing myenteric neurons thought to be 
intrinsic primary afferent neurons (IPANs, i.e., sensory neurons) (Furness et al., 2004a; Furness 
et al., 2004b). In vitro, HGF/MET signaling influences ENS precursor neurite growth and 
neuronal differentiation, but conditional Met null mutations driven by Wnt1Cre (i.e., Metfl/fl; 
Wnt1Cre+; called “Met cKO”) did not cause major ENS developmental defects.  Met cKO mice 
had a normal density of MET-IR myenteric neurons, but fewer or shorter MET-IR neurites.  Met 
cKO mice also had a specific defect in the peristaltic response elicited by mechanical 
deformation of intestinal villi, however, in vivo tests of bowel motility were unaltered. Finally, 
Met cKO mice had increased susceptibility to dextran sodium sulfate (DSS) induced mucosal 
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damage, suggesting that CGRP expressing enteric neurons protect the bowel from injury and that 
HGF’s ability to protect the bowel might depend on signaling within the ENS. 
 
3.3 Materials and Methods 
3.3.1 Animals. 
c-Metfl/WT mice (129SV/C57BL/6 background) (Huh et al., 2004) were generously provided by 
Dr. Snorri S. Thorgeirsson (NCI, NIH, Bethesda, MD).  Wnt1Cre mice (STOCK Tg(Wnt1-
Cre)11Rth Tg(Wnt1-GAL4)11Rth/J, stock # 003829, C57BL/6; Swiss albino mixed background) 
and R26R-EYFP reporter mice (B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J, Stock # 006148, 
C57BL/6J) were from The Jackson Lab.  RET-EGFP mice were previously described (Jain et al., 
2006). Etv5M/M  and Etv4-/-;Etv5lacZ/WT mice were kindly provided by Dr. Kenneth Murphy 
(Washington University School of Medicine in St. Louis, MO) and Dr. Silvia Arber (University 
of Basel, Switzerland). CF-1 mice were from Charles River. The morning of vaginal plug was 
considered embryonic day 0.5 (E0.5). The use and care of mice were accredited and approved by 
the Washington University Animal Care Committee and by The Children’s Hospital of 
Philadelphia Research Institute Institutional Animal Care and Use Committee. 
3.3.2 Antibodies and reagents. 
Primary antibodies for mouse analysis: p75NTR antibody (rabbit, 1:1000, #G323A, Promega), 
Choline acetyltransferases (Chat, goat, 1:10, #AB144P, Millipore), calretinin (rabbit, 1:2500, 
#AB5054, Chemicon), HGF (goat, 1:100, #sc-1357, Santa Cruz), HuC/D (mouse, 1:200, 
#A21272, Invitrogen), GFP (chicken, 1:1000, #GFP-1020, Aves Labs), S100B (rabbit, 1:800, 
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DAKO), PGP9.5 (guinea pig, 1:100, #GP14104, Neuromics), TuJ1 (rabbit, #PRB-435P, 1:10 
000, Covance) Tuj1 (mouse, #MMS-410P, 1:100, Covance), RET (goat, 1:200, #GT15002, 
1:100, Neuromics), MET (goat, AF527, 1:100, R&D Systems), CGRP (rabbit, #C8198, 1:100, 
Sigma), phosphohistone 3 (pH3) (rabbit AB#06-570, 1:800, Upstate), nNOS (rabbit, #AB 5380, 
1:1000, Chemicon), substance P (rabbit, 1:1000, Inestar), VIP (rabbit, 1:1000, Peninsula), NF145 
(rabbit, #ab1987, 1:100, Millipore).  Primary antibodies for human gut tissue: PGP9.5 (rabbit, 
#7863-0504, 1:100, Serotec), c-MET (goat, #AF276, 1:100, R&D Systems).  Secondary 
antibodies: donkey anti-goat Alexa 594 (1:400, Molecular Probes), donkey anti-rabbit Alexa 488 
(1:400, Molecular Probes), donkey anti-mouse Alexa 647 (1:400, Molecular Probes). Tissue 
culture reagents included GDNF (Creedon et al., 1997), HGF (mouse, #2207-HG, R&D 
Systems), Neurobasal media (Life Technologies), B27 (Life Technologies), Dulbecco’s 
Modified Eagle Medium (DMEM), glutamine (Fisher), penicillin and streptomycin (Fisher). 
Inhibitors: PD98059 (MEK1 inhibitor, #EI360-0005, Enzo life) and LY294002 (PI3K inhibitor, 
#ST420-0005 Enzo Life Sciences).  
3.3.3 Quantitative ENS analysis. 
Whole mount myenteric plexus analysis was performed using 8-12 weeks old mice (n=3-6) as 
described (Wang et al., 2010).  Briefly, gut was opened along the mesenteric border, pinned to 
Sylgard®, fixed (4% paraformaldehyde (PFA), 30 minutes, 25oC), and then dissected to separate 
muscle layers from submucosa.  After immunohistochemistry or NADPH diaphorase staining, 
quantitative analysis was performed.  For CGRP antibody staining, peeled gut muscle layers 
were cultured with colchicine (0.1 mg/mL, C9754, Sigma), DMEM, glutamine (2 mM), 
penicillin (100 IU/mL) and streptomycin (100 ug/mL) for 24 hours before fixation. Neuronal 
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density was quantified by counting cells within twenty randomly selected 20x-fields per mouse. 
At least 3 mice of each genotype were analyzed.  
3.3.4 Immunohistochemistry and image processing. 
After fixation, cells, organs or peeled gut muscle layers were kept in TBST (100 mM Tris, 150 
mM NaCl, 0.5% Triton X-100) for 30 minutes at 37°C, blocked with 5% donkey serum/TBST 
(30 minutes, 37°C) and then incubated with primary antibody (overnight, 4°C). Images were 
obtained with an Olympus BX60 microscope, Axiocam and AxioVision software (Zeiss) or with 
Zeiss Axio Imager.A2, AxioCam MRm Rev.3 Camera and ZEN software. Image processing 
included only cropping and uniform adjustments of brightness, contrast and saturation. 
3.3.5 Human gut. 
Paraformaldehyde-fixed, paraffin-embedded human colon was obtained from the Washington 
University Digestive Disease Research Core Center (DDRCC) after approval from the 
Institutional Review Board at Washington University School of Medicine. Five micron sections 
were deparaffinized and rehydrated for immunohistochemistry.  
3.3.6 DiI Labeling combined with immunohistochemistry. 
Adult mouse bowel was dissected, fixed, and peeled as for quantitative whole mount analysis. 
Muscle layers from distal small intestine were cut into 3 cm long pieces and pinned out on a 
Sylgard® dish. A dissecting pin dipped in NeuroTrace® DiI Tissue-Labeling Paste (#N-22880, 
Life Technologies) was inserted into the middle of each tissue piece. Pierced samples were kept 
in 4% PFA at 37oC for three weeks. Immunohistochemistry for MET was performed as 
described above, except that instead of Triton X-100, 1000 ug/mL digitonin (#D141 Sigma) was 
used to permeabilize tissue while preserving DiI staining (Matsubayashi et al., 2008). For cell 
counting, tissue pieces were evaluated using a 5 X 7 grid of 20X fields centered on the pin 
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insertion site. The grid was additionally subdivided into 3 zones of varying distances from the 
pin (Figure 3.5) and cells within each 20X field were counted.  
3.3.7 Dissociated cell culture. 
 E12.5 CF-1 ENS precursor cells from dissociated bowel were immunoselected with p75NTR 
antibody (1:1000) and maintained in culture as previously described (Sato and Heuckeroth, 
2008) except that GDNF was not included in media for cell dissociation or immunoselection. 
Briefly, whole bowel was treated with collagenase (0.5 mg/mL) and dispase (0.5 mg/mL), 
triturated and filtered through a 40 um cell strainer before incubation with p75NTR antibody 
(Chemicon) and goat anti-rabbit coupled paramagnetic beads (Miltenyi Biotec, GmbH).  After 
separation of p75NTR expressing cells using a MACS Separation column (Miltenyi Biotec, 
GmbH), immunoselected cells were plated at 6000 cells/well on poly-D-lysine and laminin 
coated 8-well chamber slides. Cells were cultured in Neurobasal media supplemented with B27 
(2%), glutamine (2mM), penicillin (100IU/mL), and streptomycin (100 ug/mL) for 48 hours 
before fixation with 4% paraformaldehyde and analysis by immunohistochemistry. 
3.3.8 Slice culture. 
E12.5 CF-1 gut slice cultures were performed as described (Fu et al., 2006) with minor 
modifications.  Briefly, 300-500 um long small bowel slices were cultured on fibronectin-coated 
plastic chamber slides (NuncTM Lab-TekTM, Thermo Scientic) in DMEM, B27 (2%), glutamine 
(2 mM), penicillin (100 IU/mL) and streptomycin (100 ug/mL). Immediately after plating, slices 
were treated with PBS (vehicle), HGF, or GDNF at the indicated concentration for 24 hours 
before fixation (4% PFA, 15 minutes, 25oC) and processing for immunohistochemistry. For 
analysis, the distance from the edge of the explant to the most distant TuJ1+ neurites or RET+ 
cells was determined in at least 3 and up to 8 regions per explant. 
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3.3.9 In vitro peristaltic response. 
 The colon of adult mice was opened along mesenteric attachments to form flat sheets and pinned 
mucosal side up in a three-chambered organ bath as previously described (Grider and Jin, 1994; 
Grider et al., 2010).  Force-displacement transducers were attached to the circular muscle to 
record ascending contraction in the orad peripheral compartment and descending relaxation in 
the caudad compartment.  A sensory stimulus that initiates the peristaltic reflex was applied to 
the bowel in the central chamber.  We used a hook-and-pulley system to produce graded (2-8 
grams) radial stretch of the circular muscle layer to test the stretch-activated sensory pathway.  
Mechanical deformation of villi was tested using graded mucosal stroking with a fine brush to 
stimulate the mucosal-activated pathway.  
3.3.10 Whole Gastrointestinal Transit Assay. 
Adult mice were fed by intragastric gavage with 300 µL of 6% carmine red dye solution 
(#C1022 Sigma) dissolved in distilled water containing 0.5% methylcellulose (#274429 Sigma). 
Mice then were placed into individual cages without bedding. A white sheet of paper covered the 
cage bottom to facilitate detection of carmine in fecal pellets.  Following gavage, cage bottoms 
were checked for dyed fecal pellets at 10 minute intervals. Each mouse was tested three times 
with at least three days between tests.  
3.3.11 Colon Motility Assay. 
After adult mice were anesthetized with isoflurane, a fire polished glass rod (3 mm in diameter, 
custom made by University of Pennsylvania Glass Shop) was used to insert a glass bead (3 mm 
in diameter, #Z143928, Sigma) into the rectum, 2 cm from the anal verge. The glass rod and 
beads were lubricated with sterile corn oil (#C8267 Sigma) prior to insertion. The time required 
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to eject the bead was measured as an estimate of colonic motility. Each mouse was tested three 
times with at least one day between trials.  
3.3.12 Small Intestine Transit Assay. 
Adult mice were fasted overnight and then fed by intragastic gavage with 100 uL of 10 mg/mL 
fluorescein isothiocyanate-dextran (FITC-dextran, average molecular weight 70,000, #46945 
Sigma) dissolved in distilled water containing 2% methylcellulose. Animals were euthanized 90 
minutes later and the stomach, small intestine, cecum, and colon were collected in 1X PBS.  
Small intestine was divided into 10 segments, cecum into 2 segments, and colon into 3 segments. 
Each segment was opened along the mesenteric border without losing luminal content and placed 
into an individual 1mL Eppendorf tube containing 500 uL 1X PBS. Tubes were vortexed 15 
seconds and then centrifuged (2000 x g, 10 minutes) to obtain FITC-dextran containing 
supernatant. FITC fluorescence was measured in 100 uL aliquots of supernatant in a 96-well 
plate using a FilterMax F5 (Molecular Devices) plate reader. Small intestine transit was 
evaluated by determining the geometric center of the FITC-dextran in the bowel. The geometric 
center (Miller et al., 1981) was calculated as follows: Total geometric center = ∑(fluorescence in 
each segment x segment number)/(total fluorescence recovered)  and ranges from 1 (minimum 
motility) to 16 (maximum motility).  
3.3.13 Dextran sodium sulfate (DSS) injury. 
Colitis was induced with DSS (2.5% in drinking water) as previously described (Pull et al., 
2005).  Control littermate mice were placed in separate cages at the time of the experiment and 
received water without DSS. Anatomic analysis of the colon was done on day 14 after starting 
DSS or water with the exception of bromodeoxyuridine (BrdU) experiments which were 
completed on day seven.  For BrdU studies mice received intraperitoneal injections (10 mg/mL, 
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100 ug/g body weight) and were analyzed one hour later. Colons were pinned flat mucosal side 
up and fixed (4% PFA, 30 minutes, 25oC) before gross morphologic analysis. Longitudinal 5 um 
sections of paraffin-embedded distal and proximal colon were stained with hematoxylin and 
eosin for additional analysis. 
3.3.14 Quantitative reverse transcriptase polymerase chain reaction (qRT-
PCR). 
 
Total RNA isolated using TRI Reagent (Sigma, St Louis, MO) and purified using RNeasy Mini 
kit (Qiagen Inc., Valencia, CA) was reverse-transcribed using SuperScript II Reverse 
Transcriptase for PCR cDNA synthesis (Invitrogen, Carlsbad, CA).  qRT-PCR was performed in 
duplicate using SYBR green PCR Master mix (Applied Biosystems, Foster City, CA) and an 
iCycler iQ (Bio-Rad, Hercules, CA).  Primers are in Table 3.1 
3.3.15 Statistical analysis. 
SigmaPlot 11 (Systat Software) was used for statistical analyses.  All studies included at least 3 
biological replicates.  Measurements were made by observers blinded to conditions used for 
studies.  Student’s t test or one-way ANOVA with post hoc multiple comparisons tests (Dunn or 
Holm-Sidak) were used for statistical analysis. Log-Rank testing was performed for analysis of 
the Kaplan-Meier survival curves.  Data are plotted as mean +/- SEM for all graphs.  For all 
tests, P < 0.05 was considered significant. 
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Table 3.1. Primers for qRT-PCR 
Accession 
Number 
Gene 
Symbol 
Unigene Title 
 
Sequences a 
NM_008084 GAPDH 
glyceraldehyde-3-phosphate 
dehydrogenase 
f 
r 
AAC TTT GGC ATT GTG GAA GG 
GTC TTC TGG GTG GCA GTG AT 
NM_008591 Met Met proto-oncogene  
f 
r 
CCA GCA GCT TCA GTT ACC GG 
GCG ATG CTG ACA TGC CAC TG 
NM_008815 Etv4 Ets variant gene 4 
f 
r 
CCC AGA TGA TGT CTG CAT TG 
GCC TGT CCA AGC AAT GAA AT 
NM_023794.2 Etv5 Ets variant gene 5 
f 
r 
GACCCCAGGCTGTACTTTGA 
CAGTCCAGGCGATGAAGTG 
a  5’ to 3’sequences; f = forward primer; r = reverse-strand primer  
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3.4 Results 
3.4.1 Met and HGF are expressed in a subset of adult enteric neurons.   
Immunohistochemical analysis of adult mouse small bowel demonstrated that MET is 
present in 34 +/- 6% of HuC/D+ myenteric neurons (Figure 3.1A) and that all MET+ cells 
express the pan-neuronal marker HuC/D+ (Table 3.2). As expected, MET immunoreactivity was 
not detected in S100B+ enteric glia (Figure 3.1B).  MET immunoreactive myenteric neurons 
were also detected in cross sections of human colon, where MET was co-expressed with the 
neuronal marker PGP9.5 (Figure 3.1, C, D).  To determine which enteric neuron types express 
MET, remaining studies used adult mouse small bowel whole mount preparations to facilitate 
analysis of many cells at once. Interestingly, RET and MET were detected in mutually exclusive 
subsets of myenteric neurons as confirmed by immunohistochemistry (Figure 3.1E) and by using 
a RET-EGFP reporter mouse thought to faithfully reproduce normal Ret expression patterns 
(Figure 3.1F).   100% of MET+ neurons were calcitonin gene related protein (CGRP) 
immunoreactive and 49.9+/-2.0% of CGRP+ neurons were MET+ (Figure 3.1G-I).  
MET/calretinin staining demonstrated MET immunoreactivity in 16 +/- 5% of calretinin+ cells 
and that 8+/- 2% of MET+ cells are calretinin+ (Figure 3.1J-L).  Consistent with this 
observation, since calretinin and choline acetyltransferases (CHAT) are largely expressed in the 
same cell population, we also detected MET immunoreactivity in 12 +/- 0.1% of CHAT 
immunoreactive neurons and found that 8 +/- 0.1% of MET+ neurons were CHAT+ (Figure 
3.1M-O).  There was no overlap between MET and NADPH diaphorase stained nitric oxide 
(NO) producing neurons (Figure 3.1P-R).  Thus, MET appears to be primarily expressed in a  
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Table 3.2: Immunohistochemical localization of MET and HGF in the mouse small bowel 
myenteric plexus.   
Method % of MET+ cells that are + for the 
“second marker” tested 
% of “second marker” + cells that 
are MET+ 
MET + HuC/D 100% of MET+ are HuC/D+ 34+/-6% of HuC/D+ are MET+ 
MET + S100B 0% of MET+ are S100B+ 0% of S100B+ are MET+ 
MET + CGRP 100% of MET+ are CGRP+ 49.9+/-2% of CGRP+ are MET+ 
MET + RET 
MET + RET-EGFP 
0% of MET+ are RET+ 0% of RET+ or EGFP+ are MET+ 
MET + HGF 43+/-11% of MET+ are HGF+ 100% of HGF+ are MET+ 
MET + CHAT 7.6+/-0.1% of MET+ are CHAT+ 12.3+/-0.1% of CHAT+ are MET+ 
MET + Calretinin 8.3+/-2.3% of MET+ are Calretinin+ 16.4+/-5.2% of Calretinin+ are 
MET+ 
MET + NADPHd 0% of MET are NADPHd+ 0% of NADPHd+ are MET+ 
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subset of adult CGRP expressing cells that are likely to be intrinsic primary afferent neurons 
(IPANs).  To determine where the MET ligand HGF was expressed in adult mouse bowel muscle 
layers, HGF/MET double label immunohistochemistry was performed.  Surprisingly, HGF was 
detected in 43 +/- 11% of MET+ neurons and 100% of the HGF+ neurons had MET 
immunoreactivity (Figure 3.1S-U). Finally, MET and HGF were also detected in cross sections 
of E14.5 fetal bowel (Figure 3.1V-X).  HGF immunoreactivity (Figure 3.1V) was prominent in 
the mesenchymal cells that surround the developing ENS (seen with TuJ1 in Figure 3.1W) and 
also was detected at lower levels in developing gut submucosa.  MET immunoreactivity was 
present in the region of the developing ENS, but prominent signal was also detected in gut 
epithelium and in the mesenchymal cells surrounding the ENS as well as in developing enteric 
neurons (Figure 3.1X).  This fetal immunoreactivity for HGF and MET suggested that these 
proteins might have roles during development as well as in the adult ENS. 
3.4.2 HGF and Met signaling support fetal ENS neurogenesis and neurite 
growth in vitro.   
 
To determine if HGF/Met signaling could affect fetal ENS development, we cultured 
ENS precursors from E12.5 bowel after immunoselection with p75NTR antibody.  In these 
dissociated cell cultures, we initially tried adding HGF at a range of concentrations (0-100 
ng/mL) to Neurobasal media, with B-27 supplement and L-glutamine, but in the absence of 
added GDNF, ENS precursors grew poorly or died and there was no evidence that HGF had any 
effect.  When we tried including GDNF at commonly used concentrations (e.g. 50 or 100 ng/mL) 
in the media, the trophic effects of GDNF were so strong, that no additional effect of HGF could 
be discerned. Recognizing that the concentrations of GDNF used commonly in culture are higher  
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Figure 3.1 
 
Figure 3.1.  MET immunoreactivity was detected in a subset of myenteric plexus CGRP+ 
intrinsic primary afferent neurons (IPANs).    
(A) MET-immunoreactivity was detected in 34 +/- 6% of HuC/D+ myenteric neurons of the 
adult mouse small bowel. All MET+ cells expressed the pan-neuronal marker HuC/D. (B) MET 
staining was absent from S100B+ enteric glia. (C, D) MET was detected in human myenteric 
neurons using colon cross sections. (E) MET and RET are detected in mutually exclusive sets of 
neurons as confirmed by immunohistochemistry and (F) by using a RET-EGFP reporter mouse. 
(G-I) 100% of MET+ neurons were CGRP+ and 49% of CGRP+ neurons were MET+. (J-L) 
MET was also found in 16+/-5% of calretinin+ cells and 8+/- 2% of MET+ cells are calretinin+. 
(M-O) 12 +/- 0.1% of CHAT+ cells were MET+ and 8 +/- 0.1% of MET+ neurons were 
CHAT+.  (P-R) There was no overlap between MET and NADPH diaphorase stained nitric oxide 
(NO) producing neurons.  (S-U) HGF was detected in 43 +/- 11% of MET+ neurons and 100% 
of the HGF+ neurons were MET+. (V) In cross sections of E14.5 fetal bowel HGF-IR is found in 
mesenchymal cells surrounding developing ENS stained with Tuj1 (W). (X) At E14.5, MET+ 
cells were present in the region of developing ENS as well as in gut epithelium and 
mesenchymal cells.   Scale bar in Figure 1U applies to Figures 1A, B, E-U.  Scale bar in Figure 
1D applies to C and D.  Scale bar in Figure 1X applies to V-X. N = at least 3 replicates/ staining 
condition. 
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than the ED50 for GDNF induced ENS precursor proliferation (1.5 ng/mL) (Heuckeroth et al., 
1998) and dramatically higher than the Kd for GDNF binding to GFRα1 (30 pg/mL) (Jing et al.,  
1996), we decided to titrate the GDNF to low levels that might be more physiologic, yet support 
ENS precursor survival and permit effects of HGF to be observed. Under these conditions, all 
TuJ1+ enteric neurons were also MET antibody immunoreactive (Figure 3.2A-C).  Remarkably, 
including GDNF at 1 pg/mL (50,000- to 100,000-fold less than is typically used in culture) led to 
robust and dose dependent effects of HGF (Figure 3.2D-E).  ENS precursors were therefore 
immunoselected with p75NTR and cultured at low density with 1 pg/mL GDNF plus either no 
added HGF, 1 ng/mL HGF, 20 ng/mL HGF, 50 ng/mL HGF, or 100 ng/mL HGF.  In cultures 
containing only low levels of GDNF, there were very few TuJ1+ cells in culture after 48 hours.  
Increasing HGF doses led to progressively more TuJ1+ cells in culture, with a 6-fold increase in 
TuJ1+ cells in cultures containing 100 ng/mL HGF plus 1 pg/mL GDNF compared to cells 
maintained in GDNF alone (Figure 3.2M). Including HGF in culture media also dramatically 
increased average neurite length compared to 1 pg/mL GDNF alone (Figure 3.2N).  We 
confirmed that the HGF effects are MET dependent using MET blocking antibody and 50 ng/mL 
HGF (Figure 3.2E-F, 3.2M-N).  Under these conditions, the blocking antibody almost 
completely prevented HGF effects on TuJ1+ cell number and neurite length.   
 Given the similarity of HGF and GDNF effects on the number of TuJ1+ cells in culture 
and on neurite length, we hypothesized that GDNF and HGF depend on the same signaling 
pathways to support neurogenesis and neurite growth.  We previously reported using rat enteric 
neurons that GDNF-induced increases in neuron number and neurite length depend on 
phosphatidylinositol 3-kinase (PI3K), but not MEK signaling (Srinivasan et al., 2005). Using the 
MEK inhibitor PD98059 and the PI3K inhibitor LY294002, we confirmed these findings in mice  
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Figure 3.2 
 
Figure 3.2. HGF promoted neurogenesis and neurite growth in cultured E12.5 ENS 
precursor cells. 
(A-C) E12.5 ENS precursors immunoselected with p75NTR antibody were maintained in culture 
for 48 hours in the presence of HGF plus 1 pg/mL GDNF before TuJ1 and/or MET 
immunohistochemistry and DAPI nuclear staining.  All Tuj1+ enteric neurons were MET 
immunoreactive. (D-F, M, N) HGF caused a dose dependent increase in TuJ1 immunoreactive 
neuron number and neurite length. * P < 0.05, ANOVA with Dunn’s multiple comparison test. 
(F, M, N) MET blocking antibody (Aby) reduced TuJ1+ neuron number and neurite length in 
surviving cells. Ctrl is 50 ng/mL HGF plus 1 pg/mL GDNF. ** P < 0.01, Student’s t-test. (G-L, 
O, P) When ENS precursors were grown in GDNF alone, the MEK inhibitor PD98059 (PD) had 
no effect on neuron number or neurite length, but the PI-3K inhibitor LY294002 (LY) reduced 
neuron number and neurite length. In contrast, in HGF (50 ng/mL) plus GDNF (1 pg/mL) treated 
cells, both MEK and PI-3K inhibition reduced neurite length (P), whereas only PI-3K inhibition 
reduced neuron number (O). * P < 0.01, ANOVA with Dunn’s multiple comparison test.  Scale 
bar in C applies to images A-F. Scale bar in L applies to images D-L. (N = at least 3 biological 
replicates/group; 12 individual wells/group). 
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using p75NTR immunoselected E12.5 ENS precursors in culture (Figure 3.2G-I, O, P). Similar 
to the results obtained using GDNF alone at 50 ng/mL, the number of TuJ1+ cells present after 
48 hours in culture with HGF (50 ng/mL) plus GDNF (1 pg/mL) was reduced by the PI3K 
inhibitor, but not by the MEK inhibitor.  In contrast, neurite length was reduced by both PI3K 
and MEK inhibitors in HGF containing cultures (Figure 3.2J-L), but only by the PI3K inhibitor 
in the GDNF (50 ng/mL) cultures (Figure 3.2P). This difference in downstream effectors 
suggests that HGF/MET induced neurite growth and GDNF/RET induced neurite growth support 
ENS precursors via partially overlapping signaling pathways. 
       
3.4.3 HGF/Met signaling enhances ENS precursor differentiation into neurons 
in vitro.   
 
The increase in TuJ1+ cells in dissociated ENS precursor cultures in response to HGF 
plus 1 pg/mL of GDNF could occur because of increased precursor proliferation, reduced cell 
death, or enhanced differentiation of RET+/TuJ1- precursors into RET+/TuJ1+ cells. To 
distinguish between these possibilities, dissociated p75NTR immunoselected cells from E12.5 
mouse bowel were cultured in media with GDNF (1 pg/mL) with and without HGF (50 ng/mL) 
for 48 hours and then stained with TuJ1, RET and phosphohistone 3 (pH3) antibodies (Figure 3.3 
A-H). RET is expressed in ENS precursors and differentiated neurons and TuJ1 
immunoreactivity is a marker of neuronal differentiation, whereas pH3 identifies mitotic cells. 
While the total number of RET+ cells was not significantly altered with HGF (Figure 3.3 I), the 
number of TuJ1+ cells and the proportion of RET+ cells that are TuJ1 immunoreactive was 
increased by HGF (Figure 3.3 J, K).  HGF also decreased the number of RET+TuJ1- cells in 
culture, and reduced the number of dividing (pH3+/RET+) ENS precursors (Figure 3.3 L). 
Collectively these data suggest that HGF increased the number of TuJ1+ enteric neurons in vitro  
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Figure 3.3 
 
Figure 3.3 HGF/Met signaling enhanced ENS precursor differentiation into neurons in 
vitro. 
(A-H) E12.5 ENS precursors were maintained in culture after p75NTR immunoselection for two 
days in the presence or absence of 50 ng/mL HGF prior to immunohistochemistry using RET 
(A,B), Tuj1 (C,D), and phosphohistone 3 (pH3) (E,F) antibodies as well as DAPI nuclear 
staining (A-H). (G,H) Show merged images. (I) While the total number of RET+ cells was not 
altered by HGF, the total number of TuJ1+ neurons (J) and  the percent of RET+ cells that were 
TuJ1+ (K) increased with HGF treatment. (L) The number of dividing precursor cells (pH3 and 
RET double positive) decreased with HGF treatment, suggesting that HGF increased neuronal 
differentiation and decreased proliferation. White arrows: non-mitotic RET+ pH3- ENS 
precursors. Yellow arrow: mitotic RET+PH3+ ENS precursors. White arrowhead: Ret+ TuJ1+ 
neurons.  Scale bar in G applies to all images.  (N = 3 biological replicates/group; 12 individual 
wells/group; * P < 0.01, Student’s t-test). 
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by enhancing ENS precursor differentiation into neurons instead of through increased precursor 
proliferation or survival.  
3.4.4 HGF/MET signaling did not increase ENS precursor migration in vitro.   
Since HGF and MET are expressed in fetal bowel when ENS precursors migrate and 
have well known effects on migration of other neuronal cell types (Giacobini et al., 2007; 
Garzotto et al., 2008), we hypothesized that HGF/MET signaling might influence ENS precursor 
migration.  To test this hypothesis E12.5 gut slices were cultured on fibronectin coated culture 
dishes and ENS precursors were allowed to migrate from the slice onto the culture dish for 24 
hours.  Addition of GDNF (100 ng/mL) to the media markedly increased the distance that ENS 
precursors migrated onto the culture dish (Figure 3.4).  In contrast, HGF (50 or 100 ng/mL) did 
not increase ENCDC migration onto the culture dish compared to no added factor suggesting that 
HGF may not be needed for ENCDC migration in vivo.   
3.4.5 MET inactivation within ENS precursors causes selective defects in Met 
expressing enteric neurons.   
Met-/- mice die in utero between E13.5 and E16.5 (Huh et al., 2004).  Therefore to 
investigate the role of HGF/MET signaling in the ENS in vivo we bred mice with LoxP sites 
surrounding Met exon 16 to Wnt1Cre transgenic animals to generate Met cKO mice (Metfl/fl; 
Wnt1Cre+).  CRE dependent recombination inactivates MET by removing the intracellular 
kinase domain, but should permit production of a truncated protein that includes the extracellular 
and transmembrane domain.  The Wnt1Cre transgene is expressed in the developing neural tube 
and neural crest derivatives including the ENS, but not in other cells within the bowel. Thus Met 
cKO mice should have selective loss of MET activity in ENS precursors within the bowel 
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without affecting other intestinal cell lineages.  Met cKO mice survive to adulthood and are born  
at rates that are not statistically different from expected Mendelian ratios (P > 0.99, Chi Square 
test).  
 We first tested the hypothesis that Met mutations slowed migration of ENS precursors 
down the fetal bowel, by evaluating ENS structure in Met cKO and control littermates (Met WT 
or CRE deficient) using TuJ1 and RET antibodies.  Consistent with in vitro migration studies, 
control and Met cKO mice had ENCDC in the entire small bowel and half the colon at E12.5 and 
there were no obvious differences in ENS structure (data not shown).  We then examined the 
adult mouse myenteric plexus to test the hypothesis that HGF/MET signaling influences the 
development of Met expressing CGRP+ enteric neurons.  Using an antibody to the MET 
extracellular domain to stain the myenteric plexus, we found that MET+ neuronal cell bodies are 
easy to identify in Met cKO mice and that these cells were normal in size (Figure 3.5A) and 
abundance (Figure 3.5B).  In contrast, MET-immunoreactive inter- and intra-ganglionic neurites 
are very difficult to see in Met cKO mice compared to control animals (Figure 3.5 C-D). To 
determine if this staining pattern reflects a difference in neurite length for myenteric plexus Met-
expressing neurons, we performed DiI labeling combined with MET immunohistochemistry. DiI 
paste on a dissecting pin was inserted into fixed small bowel muscle layers containing the 
myenteric plexus and tissue was incubated for three weeks. DiI taken up by axons undergoes 
passive retrograde diffusion through lipid membranes to label cell bodies away from the pin site 
(Figure 3.5E-J). Co-staining of DiI labeled samples with MET antibody revealed that the number 
of DiI and MET-double positive cell bodies was dramatically reduced in Met cKO mice 
compared to controls, especially as the distance from the DiI labeling site increased (Figure 5K,  
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Figure 3.4  
 
Figure 3.4. HGF/Met signaling did not increase ENS precursor migration in culture.  
(A-C) E12.5 gut slices were cultured 24 hours on fibronectin coated dishes with no added factor, 
HGF or GDNF before staining for RET and TuJ1. (A) ENCDC migrate from the gut slice onto 
the culture dish even without any added factors.  (B) HGF did not increase the distance that 
ENCDC migrated from the edge of the gut slice. (C) GDNF markedly increased the distance 
ENCDC migrate from the edge of the gut slice.  (D) Quantitative data (No added factor 15 slices; 
50 ng/mL HGF 14 slices; 100 ng/mL HGF 19 slices; 100 ng/mL GDNF 30 slices, N = 3 
independent experiments). * P < 0.001 for GDNF versus no added factor, ANOVA with Dunn’s 
multiple comparison test. 
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Figure 3.5 
 
Figure 3.5. MET deletion within 
ENS precursors caused selective 
defects in MET expressing 
enteric neurons in adult mice.   
(A, B) The myenteric plexus of 
mice lacking functional MET 
receptors in the ENS 
(Mettf/fWnt1Cre+) contained 
MET+ neuronal cell bodies of 
normal size and abundance. (N = 
3 mice of each 
genotype/condition). (C-D) 
Mettf/fWnt1Cre+ mice had few 
inter- and intra-ganglionic MET+ 
immunoreactive neurites. (N = 6 
mice of each genotype/condition)  
(E-J) Shows double labeling 
method for myenteric neurons 
combining DiI labeling and MET 
immunohistochemistry.  Cells 
shown were two 20X fields away 
from the DiI application site. 
Yellow arrow: DiI+ MET+ cell 
body. White arrow: DiI+ MET- 
cell body. White arrow heads: 
DiI- MET+ cell bodies. (N = 4 
mice of each genotype; N > 8 
distal small bowel Di-labeled 
regions/genotype). (K) Schematic 
for analysis of DiI/MET labeled 
samples:  tissue pieces were 
divided into a 5 X 7 grid of 20X 
fields centered on the pin insertion 
site. The grid was additionally 
subdivided into 3 zones of varying 
distances from the pin. (L,M) 
Heat map representations of the 
average number of MET+ DiI+ cells (L) and total MET+ cells (M) in each 20X field of the grid. 
Dark red > light red> blue for the number of cells in each region.  (O) The number of DiI+ 
MET+ cell bodies was dramatically reduced in Met cKO mice compared to controls in Zones 1 
and 2. * P < 0.02 (Student’s t-test).  (P) The number of total MET+ cell bodies did not differ at 
varying distances from the pin site.   
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L,O).  In contrast, the average number of MET-positive cell bodies was not different at varying 
distances away from the pin site (Figure 3.5M, P). Furthermore, the number of MET negative  
neuron cell bodies labeled by DiI did not significantly differ in WT and Met cKO mice. These 
data suggests that neurites in MET immunoreactive myenteric neurons of Met cKO mice are 
shorter than in WT mice. 
3.4.6 Functional analysis of gut motility.  
To test the hypothesis that HGF/MET signaling is important for intestinal motility, the 
peristaltic response to stretch or to mechanical stimulation of the mucosal lining was measured in 
WT and Met cKO mice using an oxygenated three-compartment organ bath.  These studies 
showed that the ascending and descending components of the peristaltic reflex were strongly 
blunted in Metfl/fl;Wnt1-Cre+ mice in response to gentle brushing of the mucosa (Figure 
3.6A,B,E).  In contrast, both components were similar in WT and Met cKO mice when the 
peristaltic reflex was elicited by muscle stretch (Figure 3.6C-D).  These data suggest that Met 
mutations cause a selective defect in one of the sensory signaling modalities capable of initiating 
peristalsis (i.e., the reflex elicited by mucosal stimulation).  Despite this defined defect in the 
peristaltic reflex, whole gastrointestinal transit as measured using carmine dye (Figure 3.6F), 
gastric emptying and small intestine transit measured by FITC-dextran gavage (Figure 3.6G), 
and colonic motility measured by expulsion of a glass bead from the rectum (Figure 3.6H), were 
not altered in Met cKO mice compared to controls.  These data suggest that intact sensory 
response to villus deformation is not required for normal transit of luminal contents through the 
bowel. 
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Figure 3.6 
 
Figure 3.6. MET deletion 
within ENS precursors 
resulted in selective 
defects in the sensory 
arm of the peristaltic 
response.  
(A, B, E) Mice lacking 
functional MET receptors 
in the ENS (Metfl/fl;Wnt1-
Cre+) had an abnormal 
peristaltic reflex in 
response to mechanical 
stimulation of the villi, as 
evidenced by a severely 
blunted ascending 
contraction (A) and 
descending relaxation (B). 
(C, D) In contrast, the 
peristaltic reflex elicited by 
circular muscle stretch had 
normal ascending 
contraction (C) and 
descending relaxation (D) 
in  Metfl/fl;Wnt1-Cre+ 
mice, suggesting a 
selective sensory defect.  
(N = 3 mice/genotype; * P 
<0.01, Student’s t-test). (F) 
Whole gastrointestinal 
transit as measured by the 
time needed to pass orally 
gavage fed carmine dye in 
stool was not altered in 
Metfl/fl;Wnt1-Cre+ mice (N = 8 Met cKO and 7 control mice).  (G) Small bowel transit as 
measured by determining the geometric center of FITC-dextran within the bowel 90 minutes 
following oral gavage was not altered in Metfl/fl;Wnt1-Cre+ mice.  (N = 4 Met cKO and 4 control 
mice).  (H) Colonic transit, as measured by the time taken to expel a bead placed 2 cm into the 
distal colon was not altered in Metfl/fl;Wnt1-Cre+ mice (N = 8 Met cKO and 7 control mice). 
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3.4.7 HGF/Met signaling and bowel injury.   
HGF/MET signaling potently reduces bowel injury in response to the toxins DSS and 
2,4,6-trinitrobenzene sulfonic acid (TNBS) in rodent models and supports epithelial cell 
proliferation (Tahara et al., 2003; Mukoyama et al., 2005; Numata et al., 2005; Oh et al., 2005; 
Hanawa et al., 2006; Kanbe et al., 2006; Setoyama et al., 2011).  We hypothesized that these 
effects might be mediated by the newly discovered MET expressing neurons.  To test this 
hypothesis we treated Metfl/fl; Wnt1Cre+ mice or control littermate animals with 2.5% DSS in 
drinking water and analyzed the colon after 2 weeks of DSS treatment.  Metfl/fl; Wnt1Cre+ mice 
had significantly more mucosal damage than control animals after 14 days of DSS treatment 
(Figure 3.7A-F) and higher death rates (Figure 7G). Because increased damage in specific 
models, including DSS, is linked to diminished epithelial proliferation, we examined intestinal 
stem and progenitor cell proliferation and found that Met cKO mice had reduced proliferation 
compared to control animals after 7 days of DSS (Figure 3.7 H-J).  Collectively these data 
suggest that HGF/MET signaling protects the intestinal mucosa from DSS induced injury 
through the activity of MET expressing enteric neurons since the only cells in the bowel that 
express CRE in this model are in the ENS. 
3.4.8 GDNF/RET signaling increased Met and Etv5 mRNA in cultured ENS 
precursors, but MET protein levels in vivo do not depend on Etv5/Etv4. 
 
The requirement for very small amounts of GDNF to detect any HGF effects on neurite 
growth and neuron numbers is striking especially since MET and RET are closely related 
tyrosine kinase receptors.  One possible explanation is that GDNF/RET signaling is needed to 
induce Met expression in cultured ENS precursors as occurs in the kidney and motor neurons via  
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Figure 3.7 
 
Figure 3.7. MET inactivation in ENS precursors diminished mucosal injury in response to 
DSS treatment.  
(A-F) Metfl/fl; Wnt1Cre+ mice and Metfl/fl; Wnt1Cre- control animals were treated with 2.5% 
DSS in drinking water for 14 days and then examined using a dissecting microscope (A, B) or 
after paraffin sectioning and hematoxylin and eosin staining (C, D).  (E, F) Quantitative analysis 
of ulcer area in the descending colon and ulcer length in the rectum demonstrated reduced ulcers 
in Metf/f; Wnt1Cre mice compared to controls. * P <0.01, Student’s t-test. (G) Kaplan-Meier 
analysis demonstrated that DSS treated Metfl/fl; Wnt1Cre+ mice had higher death rates than 
controls. (N = 8 Met cKO and 11 control mice). P < 0.05, Log-Rank test. (H-J) BrdU labeling 
after seven days of DSS treatment showed reduced colonic epithelial cell proliferation within 
crypts of Metf/f; Wnt1Cre mice compared to control animals. * P <0.01, Student’s t-test.  Yellow 
arrows: ulcerated regions.  (N = 5 Met cKO and 4 control animals/group for ulcer analysis and 
BrdU labeling). 
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the Etv4 (Pea3) and Etv5 (Erm) transcription factors (Haase et al., 2002; Livet et al., 2002; Lu et 
al., 2009; Kuure et al., 2010). To test this hypothesis we cultured E12.5 immunoselected ENS 
precursors for 18 hours with or without 1 pg/mL GDNF.  Although extended culture without 
GDNF results in death of ENS precursors, there were many healthy appearing ENS precursors in 
the GDNF deprived cultures and in cultures containing 1 pg/mL of GDNF when the mRNA was 
collected after 18 hours in culture.  Relative mRNA levels for Etv4, Etv5 and Met were analyzed 
by real time reverse transcriptase PCR (qRT-PCR).  We found that compared to cells cultured 
without GDNF, ENS precursors grown with 1 pg/mL GDNF had an 8-fold increase in Etv5 
mRNA, a 230-fold increase in Met mRNA, but no change in Etv4 mRNA.  These data suggest 
that low levels of GDNF induced Met expression, allowing HGF to affect ENS precursor 
development (Figure 3.8A-B). 
 To further explore the role of ETV5 signaling on MET expression in vivo, we examined 
MET expression in the ENS of Etv5M/M animals, as well as in Etv4-/-; Etv5lacZ/WT compound 
mutants (Lu et al., 2009). Etv5M/M allele is a weak allele that permits survival to adulthood.  In 
contrast, the Etv5lacZ allele used in the Etv4-/-; Etv5lacZ/WT mice causes early fetal lethality 
prohibiting analysis of the Etv5lacZ/lacZ ENS. We found that the ENS of Etv5M/M and Etv4-/-; 
Etv5lacZ/WT compound mutants was grossly normal, with MET-IR neuron density comparable to 
that of WT littermates (Figure 3.8 C-H)).  In contrast, in the developing kidney, where GDNF 
also induces Met expression, the Etv4-/-; Etv5lacZ/WT compound mutants fail to express Met in the 
ureteric bud causing serious defects in renal development (Lu et al., 2009). This suggests that 
ETV4 and ETV5 are dispensable for MET expression in enteric neurons or that at single allele of 
Etv5 is adequate for MET expression in the ENS. 
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Figure 3.8 
 
Figure 3.8. GDNF/Ret signaling increased Met and Etv5 mRNA in cultured ENS 
precursors, but MET protein immunoreactivity appeared normal in mice with Etv4 and 
Etv5 mutations. 
(A)  ENS precursors grown with 1 pg/mL GDNF had an 8-fold increase in Etv5 mRNA, but not 
in Etv4 mRNA when compared to precursors cultured without GDNF. (B) ENS precursors 
grown with 1pg/mL GDNF also had a 230-fold increase in Met mRNA. (N = 3 biological 
replicates) (C-H) The myenteric plexus of adult Etv5M/M mice and P14 Etv4-/-; Etv5lacZ/WT 
compound mutants appeared grossly normal with no differences in MET-IR neuron density. (N = 
3 mice for each group). *P < 0.01 (Student’s t-test). 
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3.5 Discussion   
     HGF enhanced fetal enteric neuron differentiation and neurite growth in vitro, but did not 
affect ENS precursor migration from gut slices or bowel colonization by ENS precursors in vivo.  
In adults, MET immunoreactivity was found in a subset CGRP+ myenteric neurons thought to be 
IPANs (Qu et al., 2008). MET-IR neuron density was normal in Met cKO mice, but MET-IR 
neurites were short and sparse.  Met cKO mice also had reduced peristalsis after mucosal 
deformation and increased mucosal injury after DSS exposure. These data suggest HGF and 
MET support a subset of CGRP-expressing IPANs that regulate intestinal motility and epithelial 
function. 
 
3.5.1 HGF, MET, GDNF and RET  
     MET influences many cellular functions (Trusolino et al., 2010) including neuron survival 
(spinal motor, sympathetic, sensory and retinal neurons) (Ebens et al., 1996a; Maina et al., 1997; 
Thompson et al., 2004; Lamballe et al., 2011; Tonges et al., 2011), differentiation (sensory and 
hippocampal neurons) (Maina et al., 1997; Lim and Walikonis, 2008), axon outgrowth and 
guidance (spinal motor, GNRH, sensory, and retinal neurons) (Ebens et al., 1996a; Maina et al., 
1997; Giacobini et al., 2007; Tonges et al., 2011), precursor migration (cortical and GNRH 
neurons) (Giacobini et al., 2007; Garzotto et al., 2008), and synaptic plasticity (hippocampal 
neurons) (Akimoto et al., 2004).  Our data reveal previously unsuspected roles for MET and 
HGF in the ENS, but there is more to learn.  One intriguing question is whether HGF in some 
MET-IR neurons acts as a chemoattractant to support formation of the extensive network of 
IPAN to IPAN connections (Furness et al., 2004a). HGF is chemoattractive for spinal motor 
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axons (Ebens et al., 1996b), but has autocrine roles in sympathetic neurons (Maina et al., 1998) 
and may have similar ENS functions.  Another interesting finding was that HGF effects required 
small amounts of GDNF, which increased Met and Etv5 mRNA (Lu et al., 2009; Costantini, 
2010).  In kidney Met was absent in Etv4-/-; Etv5lacZ/WT mice, but MET was readily detected in 
myenteric neurons suggesting single Etv5 alleles may support ENS Met expression. 
Unfortunately, Etv5lacZ/lacZ mice die early (Lu et al., 2009) and milder Etv5M/M mutations did not 
affect MET-IR myenteric neuron density, so ETV5 function in the ENS remains uncertain. 
Finally, MET and RET appear in non-overlapping adult myenteric neuron populations, 
highlighting the need to define mechanisms restricting receptor tyrosine kinases (e.g. RET, 
NTRK3, and MET) to specific  enteric neuron subtypes (Chalazonitis et al., 1994b; Schuchardt 
et al., 1994; Heuckeroth et al., 1999; Chalazonitis et al., 2001; Uesaka et al., 2007; Uesaka et al., 
2008). 
 
3.5.2 HGF/MET and ENS Development 
 The requirement for 1 pg/mL GDNF to observe HGF effects on ENS precursors is 
reminiscent of synergistic HGF and NGF effects in DRG. HGF alone did not support DRG 
neuron survival or axon outgrowth, but HGF enhanced survival, differentiation, and 
axonogenesis with NGF present (Maina et al., 1997; Maina et al., 1998).  In the ENS, low GDNF 
levels maintain cells as progenitors (Uesaka et al., 2013) and may support survival while 
enhancing HGF responsiveness. In contrast, high GDNF triggers neuronal differentiation and 
migration, masking HGF effects.  GDNF concentrations in vivo are unknown but are probably 
below the 50-100 ng/mL commonly used in vitro, since increased and reduced GDNF alters 
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enteric neuron number (Gianino et al., 2003; Wang et al., 2010) and the Kd for GDNF binding to 
GFRα1 is only 30 pg/mL (Jing et al., 1996).  These observations suggest that it may be 
appropriate to evaluate how other factors affect ENS precursors in the presence of low 
concentrations of GDNF instead of the levels typically used in culture. 
 
3.5.3 HGF/MET and IPAN Subtypes 
 Functional data suggest IPANs are heterogeneous (Clerc and Furness, 2004; Furness et 
al., 2004a; Furness, 2006a).  For example, stretch opens IPAN gadolinium-insensitive 
mechanosensitive ion channels (Kunze et al., 1999), whereas mucosal deformation triggers 
serotonin and ATP release from enteroendocrine cells to activate IPAN 5HT-3/5HT-4 or P2X 
receptors (Grider and Jin, 1994; Pan and Gershon, 2000; Raybould et al., 2004; Patel, 2014).  
These IPANs all express CGRP, however only 49% of CGRP+ neurons are MET+.  MET 
signaling is not needed for survival of MET-IR neurons, but Met cKO mice have impaired 
peristalsis in vitro after mucosal stroking consistent with a functional defect in a subset of 
IPANs. In contrast, bowel stretch responsive IPANS are either MET-negative or do not require 
MET for function.  It is not clear if the selective functional defect results from reduced neurite 
growth in MET+ neurons or from reduced function.  In DRG neurons, for example, MET 
enhances nociceptor peptidergic differentiation (Gascon et al., 2010). Nonetheless, in contrast to 
in vitro results, whole bowel transit, gastric emptying, small bowel transit, and colonic bead 
expulsion were normal in vivo in Met cKO mice. These data add to recent studies suggesting 
mucosal deformation induced peristalsis is not required for normal transit through the bowel, at 
least when stretch response is intact (Li et al., 2011; Heredia et al., 2013).   
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3.5.4 HGF, the ENS, and intestinal injury 
 HGF’s ability to reduce bowel injury is fascinating (Tahara et al., 2003; Arthur et al., 
2004; Mukoyama et al., 2005; Numata et al., 2005; Oh et al., 2005; Ohda et al., 2005; Hanawa et 
al., 2006; Kanbe et al., 2006; Gong, 2008; Setoyama et al., 2011).  Remarkably, Met cKO mice 
had increased mucosal damage, reduced epithelial stem and progenitor cell proliferation in 
response to injury, and increased mortality compared to controls after DSS treatment.  Although 
gut epithelial cells express Met (Prat et al., 1991), Metfl/fl Wnt1Cre mice do not express CRE in 
epithelium (Danielian et al., 1998), suggesting MET effects on epithelial proliferation after DSS 
are not cell-autonomous. 
 Many mechanisms might underlie our observations.  One hypothesis is that impaired 
injury response results from reduced CGRP release from MET+ enteric neurons.  CGRP 
mutations increased colonic damage in DSS treated mice (Thompson et al., 2008). Furthermore, 
CGRP is a potent vasodilator (Pawlik et al., 2000) and adequate mucosal blood flow may 
facilitate injured bowel repair. CGRP also supports bowel epithelial proliferation via mast cells 
and fibroblasts producing transforming growth factor alpha (Hoffmann et al., 2010) and by 
regulating gene expression in macrophages (Baliu-Pique et al., 2014) that influence the set point 
of intestinal epithelial proliferation (Baliu-Pique et al., 2014; Sun et al., 2014).  MET+ neurons 
might also support epithelial proliferation via acetylcholine release from CHAT+MET+ neurons, 
since acetylcholine enhances epithelial growth (Tutton, 1975; Lundgren et al., 2011; Gross et al., 
2012). 
 Consistent with ENS support for bowel epithelium, enteric neurons express the receptor 
for glucagon-like peptide 2, a potent epithelial mitogen (Bjerknes and Cheng, 2001; Guan et al., 
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2006) and neuronal serotonin increases epithelial proliferation (Gross et al., 2012). However, 
myenteric plexus ablation increases epithelial cell proliferation (Zucoloto et al., 1988; Holle, 
1991; Hadzijahic et al., 1993; Holle et al., 2003) and hypomorphic Ret+/- mice (Gianino et al., 
2003) had increased epithelial proliferation after small bowel resection (Hitch et al., 2012).  
These data suggest distinct enteric neuron subtypes enhance or inhibit intestinal epithelial 
proliferation, but it is unclear how these processes are integrated. 
     We also note that CRE-induced MET mutations are not restricted to the ENS in Met cKO 
mice (Danielian et al., 1998).  MET should be disrupted in CGRP expressing DRG neurons 
(Gascon et al., 2010) that might normally enhance mucosal repair (Takami et al., 2009; Engel et 
al., 2011; Engel et al., 2012; Lee et al., 2012). MET inactivation in vagal neurons (Freem et al., 
2010) could also increase severity of DSS induced injury  (Mazelin et al., 1999; Ghia et al., 
2006; Ghia et al., 2007; Van Der Zanden et al., 2009) since some vagal nuclei express Met 
(Caton et al., 2000; Wu and Levitt, 2013). Distinguishing between these possibilities is not 
straightforward, but these data fit with an emerging literature suggesting neuronal activity 
regulates intestinal epithelial progenitor proliferation and barrier function (Bjerknes and Cheng, 
2001; Nezami and Srinivasan, 2010; Hitch et al., 2012; Sharkey and Savidge, 2014).    
     It is tempting to speculate that neurogenic control underlies high rates of enterocolitis in 
children with Hirschsprung disease, a birth defect where the ENS is absent from distal bowel 
(Frykman and Short, 2012; Heuckeroth, 2013). ENS damage in inflammatory bowel disease or 
necrotizing enterocolitis may also perpetuate bowel inflammation (Margolis and Gershon, 2009; 
Zhou et al., 2013). Indeed, many ENS transmitters affect bowel inflammation and injury, 
including CGRP (Eysselein et al., 1992; Wang et al., 2006; Ramachandran et al., 2013), 
serotonin (Bischoff et al., 2009; Gershon, 2012), neuropeptide Y, vasoactive intestinal peptide 
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(Chandrasekharan et al., 2013), and substance P (Landau et al., 2007) as do enteric glia (Bush et 
al., 1998; Savidge et al., 2007), enteric neuron density (Margolis et al., 2011), and toll-like 
receptor 2 (Brun et al., 2013).  Our data reinforce this literature and suggest that new therapeutic 
strategies to treat or prevent intestinal motility or bowel inflammatory diseases may be targeted 
to the nervous system instead of the immune system.  
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Chapter 4: Axon Pathfinding in the enteric 
nervous system. 
 
Marina Avetisyan, Saya Bery, Jack Grider, Robert O. Heuckeroth. 
 
4.1 Introduction 
Enteric neuron precursors that have completed migration will differentiate into neurons 
and form integrated circuits that mediate various gut functions. One of the best characterized 
myenteric plexus circuits regulates peristalsis, the coordinated contraction and relaxation of the 
bowel necessary for proper propulsion of a food bolus down the GI tract. The peristaltic reflex 
begins with intrinsic primary afferent cells (IPANS) that sense chemical or mechanical stimuli 
from the gut lumen or bowel wall and relay this information to excitatory and inhibitory motor 
neurons via ascending and descending interneurons. Ascending cholinergic interneurons project 
rostrally onto cholinergic excitatory motor neurons that trigger contraction of the circular smooth 
muscle in the segment of bowel proximal to the sensory stimulus (Furness et al. 2004). 
Descending interneurons project caudally onto nitrergic inhibitory motor neurons. Descending 
interneurons release acetylcholine at the synapse with motor neurons, but also make nitric oxide 
(NO) which signals retrogradely at the synapse with IPANs to modulate interneuron signaling 
(ref). Inhibitory motor neurons project up to 10mm caudally (in mice) before turning to innervate 
circular muscle. Nitrergic (NO producing) motor neurons use VIP as a co-transmitter and 
mediate relaxation of the muscle distal to the sensory stimulus (Li & Furness 2000; Grider 2003). 
Both the proper rostro-caudal orientation of axons within the plexus and the innervation of the 
circular muscle are presumed critical for generating a coordinated peristaltic response. However, 
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how subsets of neurons orient their projections within the plexus and reach their final targets is 
largely unknown. 
DiI labeling of neuronal projections at E11.5-E12.5 shows that early in development the 
majority of growing neurites travel longitudinally in the caudal direction, while extension 
rostrally or circumferentially does not occur until later developmental time points (Fu et al. 2006; 
Burns et al. 2009). Early neurite orientation in the longitudinal vs. radial axis can be altered by 
BMP signaling. Treatment with BMP2/4 at E11.5 increased the percentage of fasciculated 
longitudinally-oriented fibers and decreased circumferentially-oriented fibers in whole gut 
cultures, whereas treatment with the BMP inhibitor noggin had the opposite effect (Fu et al. 
2006).  
In addition to broad neurite patterning during early development, there is evidence that 
axons of specific neuronal subpopulations are guided by specific molecular cues. Part of this 
evidence comes from mice overexpressing glial cell-line derived neurotrophic factor (GDNF) 
under the glial fibrillary acidic protein (GFAP) promoter which is first activated at E17 (Magill 
et al. 2010) These mice have an increased number of nitrergic myenteric neurons due to a 
GDNF-induced increase in proliferation of nitrergic precursors (Wang et al. 2010). They also 
display an increased density of nitrergic fibers surrounding glia within ganglia, but no increase in 
the number of nitrergic fibers innervating the circular muscle (Wang et al. 2010). This suggests 
that GDNF is inducing growth of new neurites that are selectively directed toward the GDNF-
producing glia within ganglia. Importantly, two other types of myenteric neuron examined did 
not have altered neurite patterning in the GFAP-GDNF transgenic mice, suggesting that excess 
GDNF specifically directs neurites for NO producing neurons (Wang et al. 2010). 
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A recent study also suggests that the planar cell polarity proteins Celsr3 and Fzd3 
regulate nitrergic axon trajectories. Nitrergic axons in WT mice at E12.5 primarily project 
caudally in the bowel (Fu et al. 2006).  In contrast, Celsr3 or Fzd3 knockout mice have many 
neurites misoriented in the rostral or circumferential direction (Sasselli et al. 2013). Analysis of 
adult Celsr3/Fzd3 knockouts also revealed subtle deficits in the thickness and orientation of 
neuronal nitric oxide synthase (nNOS) expressing interganglionic tracts (Sasselli et al. 2013).  
Selectivity in axon guidance is again suggested by the observation that the orientation of ChAT 
neurites is normal in Celsr3 and Fzd3 mutant mice. Using mosaic Celsr3 mutants, these effects 
were shown to be cell autonomous, as only neurons that were missing Celsr3 displayed aberrant 
axonal projection patterns (Sasselli et al. 2013). Additionally, guidance defects occurred without 
obvious accompanying differences in bowel colonization, precursor proliferation, or 
differentiation of various neuronal subtypes, suggesting a primary role in axonal pathfinding. 
Importantly, these subtle alterations in axon trajectories resulted in severe dysmotility, 
suggesting that precise ENS wiring is required for proper GI function. 
Together, these studies demonstrate the existence of distinct molecular mechanisms that 
“wire the enteric nervous system.” However, the actual cues responsible for guiding projections 
of most neuronal subtypes in the ENS to their final targets are still unknown. I therefore carried 
out broad gene expression profiling and identified 10 genes with known roles in axon guidance 
that are enriched in the ENS. One of these was the semaphorin guidance receptor, Plexin A4. I 
validated Plexin A4 ENS expression at E17.5 using in situ hybridization (ISH).  I then used a 
commercial antibody for double label immunohistochemistry (IHC) and localized Plexin A4 to a 
subset of calretinin-positive neurons.  Surprisingly, when I stained the ENS from Plexin A4 
knockout (Plexin A4 KO) mice I discovered that this antibody was non-specific - i.e., the staining 
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pattern with the “Plexin A4” antibody was similar in Plexin A4 KO and WT mice, even though 
the Plexin A4 KOs do not produce any Plexin A4 protein (Yaron et al. 2005). My work with the 
non-specific Plexin A4 antibody led directly to my studies of bowel muscularis macrophages 
(see Chapter 5). 
I next assessed ENS morphology and functional motility in Plexin A4 KO mice but was 
unable to detect any gross defects.  In several peripheral and CNS circuits, Plexin A4 acts 
redundantly with other semaphorin receptors  (Yaron et al. 2005).  My array data shows that 
Plexin A2 is also enriched in the ENS at E17.5. Since Plexin A4 and Plexin A2 are both capable 
of mediating signals from class 3 semaphorins (Pasterkamp 2012), one reasonable hypothesis is 
that Plexin A2/A4 double mutants are required to generate an ENS phenotype. 
 
4.2 Materials and Methods 
4.2.1 Animals   
The use and care of mice were accredited and approved by the Washington University Animal 
Care Committee and by The Children’s Hospital of Philadelphia Research Institute Institutional 
Animal Care and Use Committee. Wnt1Cre mice (Danielian et al., 1998 RRID: 
IMSR_JAX:003829, C57BL/6; Swiss albino mixed background) and R26R-EYFP reporter mice 
(Srinivas et al., 2001; RRID: IMSR_JAX:006148; C57BL/6J background) were from The 
Jackson Lab. Plexin A4 knockout mice (Yaron et al., 2005, RRID: MGI_3795749) were kindly 
provided by Dr. Alex Kolodkin (Johns Hopkins University School of Medicine, Baltimore, MD).  
The morning of vaginal plug was considered embryonic day 0.5 (E0.5). 
4.2.2 Antibodies and reagents 
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TuJ1 (rabbit, #PRB-435P, 1:10 000, Covance), Calretinin (rabbit, 1:2500, #AB5054, Chemicon), 
Plexin A4 (rabbit, 1:500, #NBP1-85128, Novus Biologicals).  
4.2.3 Fluorescence activated cell sorting (FACS) of ENCDC 
E17.5 whole bowel from Wnt1Cre; R26R-EYFP mice was dissected and dissociated into a single 
cell suspension as previously described (Sato and Heuckeroth, 2008). Briefly, whole bowel was 
treated with collagenase (0.5 mg/mL) and dispase (0.5 mg/mL) at 37°C for 15 minutes, triturated 
and filtered through a 40 µm cell strainer. Dissociated cells were suspended in HBSS and sorted 
based on EYFP fluorescence using a Beckman Coulter MoFlo sorter (Siteman Flow Cytometry 
Core, Washington University School of Medicine). EYFP-positive and EYFP-negative fractions 
were sorted directly into TRIzol® Reagent (Thermo Fisher Scientific #15596-026) and RNA was 
isolated according to the manufacturer’s instructions.  
4.2.4 Microarray and analysis 
Microarrays were performed using Affymetrix gene chips that contain probes for 28,000 mouse 
genes (Genome Technology Access Center, Washington University School of Medicine). N=3 
chips for EYFP-positive samples, N=4 chips for EYFP-negative samples. Gene expression data 
was analyzed using the Partek Genomics Suite. Data across multiple arrays was normalized 
using Robust Multi-array Average (RMA) and ANOVA was used to identify genes with > 2-fold 
higher expression in the EYFP-positive fraction (ENCDC) versus the EYFP-negative fraction 
(non-ENCDC) at a false discovery rate of 0.05.  
4.2.5 Whole mount preparation and immunohistochemistry 
Whole mount immunohistochemistry (IHC) was performed as previously described  (Wang et 
al., 2010). Briefly, gut was opened along the mesenteric border, pinned to Sylgard®, fixed (4% 
paraformaldehyde (PFA), 30 minutes, 25oC), and then dissected to separate muscle layers from 
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submucosa. Peeled muscle layers were blocked in 5% donkey serum in PBS with 0.5% Triton 
(PBST) for 1 hour at room temperature and then incubated with primary antibody overnight at 
4°C. Samples were washed in PBS before incubating with secondary antibodies. After rinsing 
with PBS, samples were mounted in VECTASHIELD® mounting medium with DAPI (Vector 
Laboratories H-1200). After immunohistochemistry or NADPH diaphorase (NADPHD) staining 
(Neuhuber et al., 1994), quantitative analysis was performed. 
4.2.6 Image acquisition and ENS quantification 
Stained specimens were imaged using Zeiss Axio Imager.A2 or the Zeiss LSM 710 confocal 
microscope. Image processing was performed using ImageJ software and was limited to rotation, 
cropping, uniform brightness and contrast adjustments, and maximum intensity projection of 
volumes. Neuronal density was quantified by counting cells within twenty randomly selected 
20x-fields per mouse. Fiber density was quantified as previously described (Wright-Jin et al. 
2013). Briefly, we counted the number of thick fiber bundles and thin individual fibers crossing 
only the top or left side of each square 20X image acquired. At least 3 mice of each genotype 
were analyzed. Axonal branching was quantified using AngioTool software (Zudaire et al. 
2011). 
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4.3 Results 
 
4.3.1 Identification of genes with known roles in axon guidance that are enriched in the 
developing ENS. 
To identify genes expressed in the ENS that might control axon pathfinding we used 
fluorescence activated cell sorting (FACS) to isolate cells from the E17.5 bowel of Wnt1Cre; 
R26R-EYFP mice that express YFP in enteric neurons, glia, and ENS precursors (Fig. 4.1).  
Broad microarray expression profiling was performed using Affymetrix gene chips. Gene 
expression levels in YFP-positive enteric neural crest derived cells (ENCDCs) were compared to 
expression in YFP-negative non-ENCDC surrounding cells of the bowel. Successful enrichment 
of the ENCDC population by FACS was confirmed by detection of positive control genes 
encoding various cytoskeletal proteins, transcription factors, and transmembrane receptors that 
are known to be expressed in the ENS (Table 4.1).  Additionally, detection of transcripts specific 
to enteric neuron subtypes, such as certain neurotransmitter receptors, confirmed sufficient array 
sensitivity to detect genes enriched only within a small proportion of ENCDCs (Table 4.2). A 
total of 605 genes were found to be enriched in the ENS at E17.5. Ten of these encoded cell 
surface receptors, adhesion molecules, or ligands with known roles in axon pathfinding (Table 
4.3). Seven out of these ten genes have not been previously described in the ENS. This list of 
seven genes includes several semaphorin receptors, with Plexin A4 being the most enriched.   
4.3.2 In situ hybridization (ISH) and imunohistochemistry (IHC) characterization of Plexin 
A4 in the ENS. 
ISH performed on E17.5 bowel sections confirmed ENS-enrichment of Plexin A4 (Fig. 
4.2A). Whole mount bowel IHC using a commercial antibody to Plexin A4 (Novus NBP1-
85128) revealed Plexin-A4 immunoreactivity in a subset of enteric neurons at E17.5 (Fig. 4.2 B- 
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Figure 4.1 
 
 
Figure 4.1. FACS of ENCDC from E17.5 Wnt1Cre;R26REYFP bowel. 
Representative FACS plot demonstrating clean separation of EYFP-positive and EYFP-negative 
populations from E17.5 Wnt1Cre;R26REYFP bowel. X-axis represents YFP-fluorescence level, 
Y-axis represents auto-fluorescence level. 
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Table 4.1 
Gene 
Fold Difference 
(ENS/Non-ENS) 
P-value 
Tubb3 
tubulin, beta 3 
30.8741 2.91E-05 
Snap25 
synaptosomal-associated 
protein 25 
19.9312 8.73E-06 
Fabp7 
fatty acid binding protein 7 
29.6071 2.02E-05 
Ascl1 
achaete-scute complex 
homolog 1 
21.5069 1.81E-06 
Phox2b 
paired-like homeobox 2b 
18.4885 5.43E-07 
Sox10 
SRY-box containing gene 10 
5.72831 2.84E-05 
Ret 
ret proto-oncogene 
10.5607 1.61E-05 
Ednrb 
endothelin receptor type B 
5.06597 3.49E-06 
 
Table 4.1. Enrichment of known ENS-specific transcripts. Fold differences and p-values for 
select positive control genes known to be enriched in the ENS. Data validates efficient FACS 
sorting of ENCDC and specificity of microarray results.  
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Table 4.2 
Gene 
Fold Difference 
(ENS/Non-ENS) 
P-value 
Vip 
vasoactive intestinal polypeptide 
15.11 0.000423366 
Nos1 
nitric oxide synthase 1 
7.01395 1.28E-05 
Chrna3 
cholinergic receptor, nicotinic, alpha polypeptide 
3 
34.3816 5.37E-06 
Chrna4 
cholinergic receptor, nicotinic, alpha polypeptide 
4 
2.04296 
 
0.000169 
 
Chrna5 
cholinergic receptor, nicotinic, alpha polypeptide 
5 
8.45178 
 
1.29E-05 
 
Chrna7 
cholinergic receptor, nicotinic, alpha polypeptide 
7 
2.91922 
 
0.000299 
 
Chrnb2 
cholinergic receptor, nicotinic, beta polypeptide 
2 
3.16554 
 
0.001204 
 
Chrnb4 
cholinergic receptor, nicotinic, beta polypeptide 
4 
18.4492 
 
7.35E-06 
 
Htr2b 
5-hydroxytryptamine (serotonin) receptor 2B 
3.10588 
 
0.000223 
 
Htr3a 
5-hydroxytryptamine (serotonin) receptor 3A 
8.89596 
 
0.000113 
 
Htr3b 
5-hydroxytryptamine (serotonin) receptor 3B 
2.23312 
 
0.000913 
 
Cnr1 
cannabinoid receptor 1 
4.6952 
 
0.000568 
 
Tacr3 
tachykinin receptor 3 
2.0943 
 
0.003219 
 
Gabrb3 
gamma-aminobutyric acid 
4.13815 
 
0.000249 
 
Gabrg2 
gamma-aminobutyric acid (GABA) A receptor, 
subunit gamma 2 
2.26019 0.000242056 
Gabrg3 
gamma-aminobutyric acid (GABA) A receptor, 
subunit gamma 3 
2.48097 0.00190814 
Grik2 16.0038 5.72E-06 
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glutamate receptor, ionotropic, kainate 2 (beta 2)   
Grik3 
glutamate receptor, ionotropic, kainate 3 (beta 3) 
6.74 
 
8.16E-05 
 
Gria2 
glutamate receptor, ionotropic, AMPA2 
9.07007 
 
5.50E-06 
 
 
Table 4.2. Enrichment of enteric neuron subtype-specific transcripts. Fold differences and p-
values for genes expressed only in some enteric neuron subtypes. Data validates sensitivity of 
microarray to lower abundance transcripts. 
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Table 4.3 
Gene 
Fold Difference 
(ENS/Non-
ENS) 
P-value 
Known 
Ligands/Receptors 
Ncam2* 
neural cell adhesion 
molecule 2 
12.2577 1.94E-05 Ncam2 (homophillic)  
L1cam* 
L1 cell adhesion molecule 
11.6346 6.82E-05 
L1cam (homophillic), 
Sema3A , Nrp1, Cntn2  
Mdga2 
MAM domain containing 
glycosylphosphatidylinositol 
anchor 2 
10.444 9.15E-05 Mdga2 (homophillic)  
Nrcam 
neuron-glia-CAM-related 
cell adhesion molecule 
7.30816 3.67E-05 
Sema3B, Sema3F, 
Sema6D, Nrp1  
Plxna4 
plexin A4 
4.69611 4.23E-05 Sema3A, Sema3F  
Slit1 
slit homolog 1 
3.44642 1.22E-05 Robo1, Robo2  
Plxnb1 
plexin B1 
3.05096 3.85E-05 Sema3A, Sema3C  
Plxna2 
plexin A2 
2.69268 0.000238 
Sema3A, Sema3C, 
Sema3F  
Sema3c 
semaphorin 3C 
2.57924 0.000674 
Nrp1, Nrp2, Plxna1, 
Plxna2, Plxnb1, 
Plxnd1,  
Ncam1* 
neural cell adhesion 
molecule 1 
2.4047 9.88E-05 
Ncam1 (homophillic), 
GDNF  
 
Table 4.3. Enrichment of genes with known roles in axon pathfinding. ENCDC enriched 
transcripts encoding cell surface receptors, adhesion molecules, or ligands with known roles in 
axon pathfinding. Asterisks indicate genes previously described in the ENS.  
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C) as well as in a subset of Iba1-positive muscularis macrophages in adult tissue (Fig. 4.2 D-F).  
Using this antibody we also found that Plexin A4 was localized to a subset of calretinin-positive 
axons present both in the myenteric plexus (Fig 4.3 A-C) as well as in the circular muscle (Fig 
4.3 D-F). Unfortunately, IHC of the bowel of Plexin A4 knockout mice that do not produce any 
Plexin A4 protein (Yaron et al. 2005) revealed identical staining patterns in the WT and KO 
using this antibody (Fig. 4.4). We attempted to clarify which neuronal subtypes express Plexin 
A4 using two other published, non-commercial Plexin A4 antibodies (Yamashita et al. 2014; Sun 
et al. 2013), but were unable to obtain reliable signal in the ENS using either antibody.  
4.3.3 Plexin A4 KO mice have no gross defects in ENS fiber patterning or neuron number. 
Since both microarray and ISH results suggested Plexin A4 enrichment in ENCDC, we decided 
to analyze neurite patterning in the ENS of Plexin A4 KO mice. No difference in TuJ1-positive 
fiber density was detected in the myenteric or submucosal plexus of Plexin A4 KO mice (Fig.4. 
5A-H). Additionally, we performed automated branch-point analysis using AngioTool software 
(Zudaire et al. 2011) but did not detect any differences in branching patterns of TuJ1-positive 
circular muscle fibers (Fig. 4.5I-K). Similarly, no differences in HuC/D-positive neuron numbers 
were seen in the myenteric or submucosal plexus of Plexin A4 KO mice (Fig. 4.5.L-Q).  To 
perform a more detailed analysis of ENS patterning in Plexin A4 KO mice, we also analyzed the 
fibers of calretinin and nNOS expressing neurons. These neurotransmitters are found in largely 
non-overlapping enteric neuron subsets, with nNOS labeling primarily inhibitory motor neurons 
and calretinin labeling primarily excitatory motor neurons.  Both neurotransmitters are also 
present in various interneurons, and calretinin is found in some IPANs (Furness et al. 2004). 
Using IHC to visualize calretinin and enzymatic NADPH-diaphorase staining to visualize nNOS  
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Figure 4.2 
 
Figure 4.2. Confirmation of Plxna4 expression in the enteric nervous system. 
(A) ISH demonstrating Plxna4 expression in E17.5 bowel sections in the region of the 
developing enteric nervous system (Ent) but not in epithelium (Epi). (B,C) Plexin A4-
immunoreactivity was detected exclusively in a subset of enteric neuron fibers at E17.5. (D-E) 
Plexin A4-immunoreactivity in a subset of neuronal fibers persists into adulthood, but was also 
detected in Iba1-positive cells (D-F).  
 
 
 
 
 
 
 
89 
 
Figure 4.3 
 
Figure 4.3. Plexin A4-immunoreactivity is found in a subset of calretinin-positive fibers in 
the ENS. 
(A-C) Plexin A4-immunoreactive puncta co-localize with some but not all calretinin-positive 
fibers in the myenteric plexus as well as in the circular muscle (D-F). Insets represent 4X 
magnifications of fibers in D-F.   
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Figure 4.4 
 
 
Figure 4.4. The Plexin A4 antibody, Novus NBP1-85128, is not specific to Plexin A4 protein. 
(A-B) Immunoreactivity to the Novus NBP1-85128 anti-Plexin A4 antibody is unchanged in 
Plexin A4 knockout mice that are entirely missing Plexin A4 protein.  
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Figure 4.5
 
Figure 4.5. The enteric nervous system of Plexin A4 KO mice has no gross defects in 
neurite patterning or neuron number.  
The myenteric (A-D) and submucosal (E-H) plexuses of Plexin A4 KO mice have normal 
density of TuJ1-positive thick fiber bundles and thin fibers. (I-K) Plexin A4 KO mice have no 
alterations in TuJ1-positive fiber branching in the circular muscle. Plexin A4 KO mice have 
normal numbers of HuC/D-positive neurons in the myenteric (L-M) and submucosal (O-P) 
plexuses. N = 3 KO, 3 WT. 
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neurons, we find no difference in the fiber density or neuron number of either neuronal 
population in Plexin A4 KO mice (Fig. 4.6).  
4.3.4 Plexin A4 KO mice have an intact peristalsis reflex. 
Despite a lack of gross anatomic defects in the myenteric or submucosal plexus of Plexin 
A4 KO ENS, it is possible that analysis with the broad markers used would not detect subtle 
patterning defects affecting only a small subset of neurons. Such subtle defects can still translate 
to severe motility problems, as is the case in Celsr3 mutants (Sasselli et al. 2013). We therefore 
assessed motility in Plexin A4 KO mice using an established ex-vivo peristalsis assay that tests 
ascending contraction and descending relaxation in response to stretch or to mechanical 
stimulation of the mucosal lining. We find that all sensory and motor components of the 
peristaltic reflex were intact in Plexin A4 KO mice (Fig. 4.7 A-D).  
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Figure 4.6 
 
Figure 4.6. Plexin A4 KO mice have no defects in calretinin or nitrergic neurite patterning 
or neuron number.  
(A-B) NADPHD labeling of nitrergic neurons shows no difference in fiber density (C-D) or 
nitrergic neuron number (E) in Plexin A4 KO mice. (F-G) IHC for calretinin shows no difference 
in fiber density (H-I) or calretinin neuron number (J) in Plexin A4 KO mice. N=3 KO, 3 WT. 
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Figure 4.7 
 
Figure 4.7. Plexin A4 KO mice have an intact peristaltic reflex.  
Mice lacking Plexin A4 exhibit normal ascending contraction and descending relaxation in 
response to mechanical stimulation of the villi (A-B) or bowel stretch (C-D). N=3 KO, 2 WT. 
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4.4 Discussion 
 Axons belonging to different neuronal subtypes in the ENS differ in their rostro-caudal 
and longitudinal vs. radial orientations, as well as in their ultimate targets (Sang et al. 1997; 
Hendriks et al. 1990) suggesting that neurons are equipped with mechanisms to sense 
directionality within the bowel and grow towards a particular target during development.  The 
nature of these mechanisms remains largely unknown. We sought to identify which genes with 
known roles in axon guidance are enriched in the developing ENS, and assessed the role of one 
such gene, Plexin A4, in establishing ENS connectivity.  
4.4.1 Novel axon guidance genes in the ENS. 
Axon pathfinding relies on the coordinated interplay of guidance cues providing 
directional information and cell adhesion molecules that enable axonal progression. We therefore 
screened for genes encoding both guidance cue receptors and ligands, as well as adhesion 
molecules with known roles in axon navigation. We identified seven genes encoding cell surface 
receptors, adhesion molecules, or ligands with known roles in axon pathfinding that are enriched 
in the ENS at E17.5, a time when neural connectivity is being established in the bowel.  Four of 
these genes encoded plexins or semaphorins. The remaining three included the cell adhesion 
molecules MDGA2 and NrCAM, and the ROBO receptor ligand, SLIT1.  
MDGA2, a cell adhesion molecule of the IgCAM superfamily, is highly expressed in 
DRG as well as in dorsolateral commissural spinal interneurons (Joset et al. 2011). In response to 
chemoattractive cues produced by floorplate cells in the ventral midline of the developing spinal 
cord, dorsolateral interneurons project ventrally, cross the floorplate, and turn orthogonally to 
run alongside the floorplate into the longitudinal axis of the spinal cord (Kaprielian et al. 2000; 
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Joset et al. 2011). RNAi and binding studies suggest that homophilic MDGA2 interactions 
between ipsilaterally projecting axons and post-crossing dorsolateral interneuron axons are 
required for the orthogonal projection of axons following commissure crossing (Joset et al. 
2011). Interestingly, many long-range guidance cues that instruct commissural crossing (Sonic 
hedgehog, netrins, Wnt) in concert with cell adhesion molecules, are also present during ENS 
development (Lake & Heuckeroth 2013; Avetisyan et al. 2015; Obermayr et al. 2013).  
 NrCAM, a cell adhesion molecule of the L1 family of immunoglobulin super family, has 
many diverse roles in neural development, including a role in axon guidance (Sakurai 2012). 
Mice missing NrCAM display wiring defects in several CNS circuits and exhibit mis-projection 
of cerebellar granule cells (Stoeckli 2010), defects in commissural axons crossing the ventral 
midline of the spinal cord (Charoy et al. 2012), defects in optic chiasm formation (Sakurai 2012), 
and mis-targeting of thalamocortical projections (Demyanenko et al. 2011). Interestingly, 
NrCAM can complex with the semaphorin co-receptor Neuropilin1 to mediate semaphorin 
signaling by Sema3B, Sema3F, and Sema6D (Pasterkamp 2012). NrCAM also represents a 
curious intersection between semaphorin and GDNF signaling. GDNF produced by floorplate 
cells in the ventral midline induces responsiveness of certain commissural spinal neurons to the 
midline repellent, Sema3B (Charoy et al. 2012). This is accomplished through suppression of 
calpain-mediated processing of the Sema3B co-receptor, Plexin A1. This effect on spinal 
neurons is mediated by GDNF signaling through Gfrα1/NrCAM complexes in a RET-
independent manner (Charoy et al. 2012). GDNF-mediated regulation of enteric neuron 
competence to respond to various guidance cues is an interesting and unexplored area of 
research. 
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SLIT1 is a secreted glycoprotein guidance cue that signals through ROBO1/2 receptors to 
regulate axon guidance in a variety of systems (Long et al. 2004). SLIT/ROBO signaling 
controls formation of the lateral olfactory tract (Nguyen-Ba-Charvet et al. 2002), guidance of 
midbrain dopaminergic axons through the diencephalon (Dugan et al. 2011), axon pathfinding 
within the postoptic commissure in the forebrain (Miquelajáuregui et al. 2014), motor axon 
pathfinding in the hindbrain (Hammond et al. 2005), retinal ganglion cell axon guidance 
(Thompson et al. 2006), and midline commissural axon crossing in the spinal cord (Long et al. 
2004). In all of these examples, SLIT1 is produced in the surrounding environment and acts on 
ROBO receptors in neurons. However, we see an enrichment of the SLIT1 ligand in developing 
ENS cells. It is possible that Slit1 is enriched and secreted by enteric glia, which are also labeled 
in the Wnt1Cre; R26R-EYFP reporter mouse. Alternatively, Slit1 expression by neurons has been 
shown to mediate migration of newly born neurons in the adult rostral migratory stream (Kaneko 
et al. 2010). SLIT1 production by these new neurons triggers ROBO-mediated repulsion of 
astrocyte processes, creating “astrocytic tunnels” that allow for neuronal migration in the adult 
brain (Kaneko et al. 2010). Slit1 expression by enteric neurons could serve a similar clearing 
function, allowing for movement of cell bodies or axons within an already formed plexus.    
4.4.2 Plexin A4 signaling in the ENS 
 Plexins and semaphorins represent the largest group of axon guidance molecules enriched 
in the developing ENS, with Plexin A4 enriched nearly 5-fold compared to non-ENS 
surrounding cells in the bowel. Binding of semaphorins to plexin and neuropilin receptors 
induces activates the plexin GTPase-activating protein (GAP) domain (Hota & Buck 2012; 
Pasterkamp 2012) and downstream signaling through protein kinases, GTPases and 
cytoskeleton-associated proteins that cause alterations in growth cone dynamics. Multiple 
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semaphorin ligands can activate a single plexin receptor, and multiple plexin receptors are 
responsive to a single semaphorin ligand (Pasterkamp 2012). Plexin A4 knockout mice have mild 
but detectable defects in the trajectories of peripheral sensory axons, sympathetic axons, and 
cranial axons. These defects are far more severe in Plexin A4/A3 double knockouts (Yaron et al. 
2005). Plexin A4 KO mice also have severe defects in the anterior commissure that are not 
enhanced in Plexin A4/A3 double knockouts (Yaron et al. 2005), suggesting that plexins function 
redundantly in some but not all neural circuits. 
 Since ISH of E17.5 bowel sections confirmed high levels of Plexin A4 expression in the 
ENS, we decided to assess the ENS of Plexin A4 KO mice. However, we were unable to detect 
any morphological defects in axon patterning or functional motility defects in peristalsis. It is 
possible that Plexin A4 functions redundantly with Plexin A2, which is also enriched in the ENS. 
Plexin A2 and A4 are both capable of transmitting signals from Sema3A, Sema3C, Sema3F, as 
well as Sema6A (Hota & Buck 2012), so it is conceivable that unmasking an ENS phenotype 
would require Plexin A2/A4 double knockouts. Alternatively, Plexin A4 single knockouts may 
have an ENS phenotype that is too subtle to detect with the broad staining methods used in our 
studies. Detection of subtle patterning defects, such as those that may be present if only a small 
subset of enteric neurons is affected, may require tracing of individual axons from Plexin-A4 
expressing neurons.  
4.4.3 ENS connectivity and disease. 
Defects in ENS connectivity may be present in several enteropathies characterized by 
subtle abnormalities in plexus organization or smooth muscle innervation (Di Nardo et al. 2008) . 
An example of such an enteropathy is the rare congenital disorder called chronic idiopathic 
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intestinal pseudoobstruction (CIIP). CIIP is a poorly understood but highly morbid syndrome 
characterized by impaired GI propulsion and symptoms of intestinal obstruction in the absence 
of any lesion or physical blockage in the gut lumen (Amiot et al. 2009; Faure et al. 1999). 
Altered connectivity may also contribute to certain cases of irritable bowel syndrome (IBS), a 
disorder that features abdominal pain and altered intestinal motility and affects 10-15% of the 
USA population (Ohman & Simrén 2010; Agarwal & Spiegel 2011). Additionally, enteric 
neuron death can occur as a consequence of infectious agents, neurodegenerative disorders such 
as Parkinson’s disease, and metabolic diseases such as diabetes (Obermayr et al. 2013). 
Successful regenerative therapies for these conditions must include strategies to reestablish 
proper connectivity in addition to replenishing neuron number. Such strategies would be greatly 
informed by knowledge of how ENS connectivity is established during development. 
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Chapter 5: Muscularis macrophage 
development and the ENS. 
 
Marina Avetisyan, Julia Rood, Rajarshi Sengupta, Elizabeth Wright-Jin, Edward M. Behrens, 
Robert O. Heuckeroth. 
 
5.1 Introduction 
Muscularis macrophages (MMs) are tissue resident macrophages found within and 
between the circular and longitudinal muscle layers of the bowel wall. These cells interact 
closely with enteric neurons in the myenteric plexus (Gabanyi et al. 2016; Phillips & Powley 
2012) and represent a unique population of bowel macrophages that differs morphologically 
(Mikkelsen et al. 2011), transcriptionally (Gabanyi et al. 2016), and likely functionally from 
neighboring macrophages in the bowel mucosa and lamina propria.   
Tissue resident macrophages were initially thought to be derived from adult blood 
circulating monocyctes. Elegant lineage tracing studies have subsequently shown that beginning 
at E8.5, all fetal tissues are initially seeded by macrophage progenitors from the yolk-sac 
(Hoeffel & Ginhoux 2015). At E12.5, a second wave of progenitors originating in the fetal-liver 
seeds all fetal tissues, with the exception of the brain which is isolated by the blood-brain barrier 
by E13.5 (Hoeffel et al. 2015; Daneman et al. 2010). These fetal-liver progenitors differentiate 
into macrophages and eventually outnumber yolk-sac derived macrophages in all tissues except 
the brain (Hoeffel & Ginhoux 2015; Ginhoux & Jung 2014; Ginhoux et al. 2010). 
Embryonically-derived macrophages retain the capacity to self-renew in situ, and at steady state 
will not be replaced by circulating bone-marrow derived monocytes (Hoeffel & Ginhoux 2015). 
The bowel is a notable exception to this developmental scheme, and it appears that constant 
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monocyte recruitment is required to maintain the mucosal and lamina propria macrophage 
population over time (Bain et al. 2014). Lineage tracing studies indicate that numbers of 
embryonically-derived macrophages in the bowel decrease with age in mice (Bain et al. 2014). 
Additionally, aged mice lacking the CCL2 chemokine receptor, CCR2, which is required for 
monocyte infiltration into the bowel (Kurihara et al. 1997) have dramatically reduced numbers of 
intestinal macrophages (Bain et al. 2014). Interestingly, we find that numbers of MMs in aged 
CCR2 knockout mice remain stable, suggesting a different maintenance mechanism for this 
macrophage population in the bowel. These findings further highlight the emerging idea that 
MMs represent a unique population of bowel macrophages.   
Initial characterizations of muscularis macrophages in the muscle layers of the bowel 
reported frequent tight contact points between macrophage processes and the surface of 
myenteric neurons in a “lock-and-key” configuration (Mikkelsen et al. 2004; Phillips & Powley 
2012) This suggested close communication between these two cell types, however the exact 
signals being exchanged are just beginning to be characterized. A recent study reported that 
muscularis macrophages produce BMP2 which alters enteric neuron activity and subsequently 
bowel motility (Muller et al. 2014). The same study reports that enteric neurons appear to be the 
main source of the MM survival factor CSF1 in the adult bowel. Several groups have now 
reported that neuronal signaling within the bowel skews MM phenotype towards an anti-
inflammatory, tissue protective one (Matteoli et al. 2014; Gabanyi et al. 2016). A cholinergic 
anti-inflammatory pathway has been described in which vagal parasympathetic efferents signal 
onto cholinergic enteric neurons to reduce Ca2+ influx and cytokine production within MMs in a 
α7nAChR-dependent manner (Matteoli et al. 2014). Additionally, sympathetic efferents from the 
celiac and superior mesenteric ganglia release norepinephrine onto β2-adrenergic receptors on 
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MMs to initiate an “anti-inflammatory” transcriptional profile (Gabanyi et al. 2016). However, 
there is also evidence that neuronal signals, such as CGRP, serve as pro-inflammatory agents for 
muscularis macrophages (Glowka et al. 2015), and it is likely that MMs integrate both pro- and 
anti-inflammatory cues originating in specific neuronal subtypes.   
Investigation of neuronal signaling onto MMs has thus far been restricted to analysis of 
adult animals. However, MMs and enteric neurons exist in close contact for days within the 
developing bowel. Op/Op mice with mutations in Csf1 and consequent macrophage depletion 
have defects in adult ENS patterning (Muller et al. 2014; Thuneberg 1999), suggesting that 
developmental signaling between these two cell types can have lasting consequences. Clarifying 
the developmental interplay between enteric neurons and muscularis macrophages may be of 
particular relevance to understanding what role, if any, MMs have in the pathogenesis of 
Hirschsprung’s associated enterocolitis (HAEC).  Hirschsprung disease (HSCR) is a birth defect 
where the enteric nervous system is absent from distal bowel.  HAEC is severe and persistent 
bowel inflammation in the context of Hirschsprung’s disease that is the leading cause of death in 
babies with  this disease (Gosain 2016). 
 To determine if enteric neurons are important for aspects of MM development, we 
analyzed the bowel of Ret KO mice that are missing enteric neurons throughout the digestive 
tract (Schuchardt et al. 1994). These mice provide a good model for studying muscularis 
macrophage development in the absence of enteric neural crest derived cells (ENCDC), 
including enteric neurons. Sympathetic innervation in the bowel of these animals is also 
defective in these animals (Enomoto et al. 2001). We find that, surprisingly, Ret KO muscularis 
externa devoid of enteric neurons contains normal numbers of well-patterned MMs that are 
phenotypically similar to control neonatal MMs. Consistent with this, we show that the main 
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source of CSF1 in the developing bowel is non-neuronal.  LPS stimulation of muscularis externa 
also failed to produce a differential response in Ret KO vs control tissue. Together these findings 
argue that the neuronal circuitry responsible for modulating MM activation status in adults is not 
present or fully mature in the newborn bowel. This in turn suggests that there is a critical post-
natal time period during which this neuro-immune circuitry develops and may be perturbed by 
environmental factors. 
5.2 Materials and Methods 
5.2.1 Animals 
The use and care of mice were accredited and approved by the Children’s Hospital of 
Philadelphia Research Institute Institutional Animal Care and Use Committee. The morning of 
vaginal plug was considered embryonic day 0.5 (E0.5). Ret-TGM mice (RRID:MGI_3623107, 
called Ret KO), were previously described (Enomoto et al. 2001). Ccr2 KO mice have been 
previously described (Boring et al. 1997) and were from Jackson Labs (stock #017586). Cx3cr1-
EGFP mice were from Jackson Labs (stock #005582).  
5.2.2 Generation of Ednrb-GFP-L10a mice 
 Ednrb-GFP-L10a mice were made by cloning a GFP-L10a fusion construct (Heiman et al. 
2008) into the multiple cloning region of a vector containing the promoter and enhancer 
sequences of endothelin receptor B fused to splicing donor and acceptor sequences of the rabbit 
β-globin gene containing an intron and polyA sequences (Nishiyama et al. 2012) using In-Fusion 
(Clontech) cloning reagents (Sup. Fig 5.2). This vector was 87 injected into the pronucleus of 
hybrid CBA;C57BL/6 fertilized oocytes. Founders were screened by PCR using the primers 5’-
GCACGACTTCTTCAAGTCCGCCATGCC-3’ (forward) and 5’- 
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CGGATCTTGAAGTTCACCTTGATGCC-3’ (reverse). Sixteen founder mice were obtained 
and screened for adult and embryonic ENS expression. A single founder line (line 16) was bred 
to C57BL/6 mice to produce embryonic mice for these studies. Ednrb-GFP-L10a transgenic 
mice were subsequently identified by GFP fluorescence. 
 
5.2.3 Antibodies and reagents  
Primary antibodies: Iba1 (rabbit, Wako Cat# 019-19741, RRID:AB_2313566, 1:500), TuJ1 
(rabbit, Covance Research Products Inc Cat# PRB-435P-100, RRID:AB_10063850, 1:10,000), 
TuJ1 (chicken, Aves Labs Cat# TUJ, RRID:AB_2313564, 1:500), HuC/D (human ANNA–1 
antiserum kindly provided by Vanda Lennon, Mayo Clinic, RRID:AB_2313944, 1:2000), 
Secondary antibodies: donkey anti-rabbit, goat anti-chick, goat anti-human Alexa fluor-488, -
594, or -647, Invitrogen, 1:400). 
5.2.4 Whole mount muscularis externa preparation and 
immunohistochemistry   
Whole mount immunohistochemistry (IHC) was performed using P0 or 8-week old mice as 
previously described (Wang et al. 2010). Briefly, gut was opened along the mesenteric border, 
pinned to Sylgard®, fixed (4% paraformaldehyde (PFA), 30 minutes, 25oC), and then dissected 
to separate muscle layers from submucosa. Peeled muscle layers were blocked in 5% donkey 
serum in PBS with 0.5% Triton (PBST) for 1 hour at room temperature and then incubated with 
primary antibody overnight at 4°C. Samples were washed in PBS before incubating with 
secondary antibodies. After rinsing with PBS, samples were mounted in VECTASHIELD® 
mounting medium with DAPI (Vector Laboratories H-1200). For P0 bowel, only distal small 
intestine muscle layers could be dissected to reliably generate samples for 
immunohistochemistry (IHC) and imaging.   
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5.2.5 Image acquisition and analysis for in situ quantification of muscularis 
macrophages  
 
Stained specimens were imaged using confocal microscopy (Zeiss LSM 710) to capture the full 
thickness of the muscle layers of the bowel.   Macrophages were counted in three separate planes 
within the muscularis (circular muscle plane, myenteric plexus plane, and longitudinal muscle 
plane) by counting cells within twenty randomly selected 20x-fields per mouse. For P0 bowel 
only ten randomly selected 20x fields were counted because of the small amount of tissue 
available. At least 4 mice of each genotype were analyzed. Image processing was performed 
using ImageJ software and was limited to rotation, cropping, uniform brightness and contrast 
adjustments, and maximum intensity projection of volumes.  
5.2.6 Flow cytometric analysis of muscularis macrophages from P0 bowel 
P0 bowel muscle layers were dissected and digested in collagenase (0.5 mg/mL) and dispase (0.5 
mg/mL) in HBSS at 37 oC for 20 minutes. Digested samples were triturated using a P1000 pipette 
and filtered through a 40 µm cell strainer before proceeding to staining. Cells were stained with 
LIVE/DEAD Aqua fixable viability dye (ThermoFisher) in PBS for 30 minutes at 4 oC, Fc blocked 
with purified CD16/CD32 antibody (clone 2.4G2) for 15 minutes at 4 oC, washed, and stained with 
fluorophore-conjugated antibodies in PBS/2%FBS for 30 minutes at 4 oC.  The following 
antibodies were used for staining: CD11b APC Cy7 (clone M1/70), CD40 FITC (clone 3/23), 
CD86 APC (GL1), and MHC Class II (I-A/I-E) PE (clone M5/114.15.2) from BD Pharmingen; 
F4/80 PerCP Cy5.5 (clone BM8) and CD115 (CSF1R) PE Cy7 (clone AFS98) from eBioscience. 
All samples were acquired on a MACSQuant flow cytometer (Miltenyi Biotec) and analyzed using 
FlowJo software version 9.9 (Tree Star). Gating strategy was adapted from (Koscsó et al. 2015). 
5.2.7 Ex vivo LPS stimulation 
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P0 distal small bowel muscularis whole mount preparations were performed in designated 
Sylgard plates to avoid LPS contamination.  Unfixed peeled muscularis samples were briefly 
dipped in 3% hydrogen peroxide in 1X PBS, then rinsed with PBS and placed into 24-well plates 
with 200 µL Iscove’s DMEM with or without 100 ng/mL LPS (Sigma #L4391). After incubation 
at 37°C for 6 hours gut specimens were processed for qRT-PCR. Supernatants were analyzed for 
IL-6 and TNF by OptEIA ELISA (BD Biosciences #555268, #555240, and #555256, 
respectively) according to the manufacturer’s instructions.  
5.2.8 qRT-PCR 
Total RNA was isolated using RNeasy Mini Kit (Qiagen #74104) and reverse-transcribed using 
SuperScript II Reverse Transcriptase for cDNA synthesis (Invitrogen #18064014).  qRT-PCR 
was performed on at least three biological replicates with three technical replicates per run using 
SsoFast™ EvaGreen® Supermix with Low ROX (Bio-Rad #1725211) and Bio-Rad Cycler 
CFX96. Primers are listed in Table 5.1.  
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Table 5.1 
Primers for qRT-PCR 
Accession 
Number 
Gene 
Symbol 
Unigene Title 
 
Sequences a 
NM_023279.2 Tubb3 Tubulin, beta 3 class III 
f 
r 
TAGACCCCAGCGGCAACTAT 
GTTCCAGGTTCCAAGTCCACC 
NM_011437.1 Sox10 
SRY-box containing 
gene 10 
f 
r 
GACCAGTACCCTCACCTCCA 
CCTCCAGAGCTTGCCTAGTG 
NM_001136061.
2 
Ednrb 
Endothelin receptor type 
B 
f 
r 
ACCGTGGTTTAACGCCATAG 
GTATGCCTCCGAGAGAGCTG 
NM_007392 Acta2 
Alpha smooth muscle 
actin 
f 
r 
GTCCCAGACATCAGGGAGTAA 
TCGGATACTTCAGCGTCAGGA 
NM_001113529.
1 
Csf1 
Colony stimulating 
factor 1  
f 
r 
AGTATTGCCAAGGAGGTGTCAG 
ATCTGGCATGAAGTCTCCATTT 
NM_001314054.
1 
Il6 Interleukin 6 
f 
r 
TGGGGCTCTTCAAAAGCTCC 
AGGAACTATCACCGGATCTTCAA 
NM_001278601.
1 
Tnfα Tumor necrosis factor 
f 
r 
CCCTCACACTCAGATCATCTTCT 
GCTACGACGTGGGCTACAG 
NM_008084 Gapdh 
glyceraldehyde-3-
phosphate 
dehydrogenase 
f 
r 
AAC TTT GGC ATT GTG GAA GG 
GTC TTC TGG GTG GCA GTG AT 
a  5’ to 3’sequences; f = forward primer; r = reverse-strand primer  
Table 5.1. Primers for qRT-PCR 
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5.3 Results 
 
5.3.1 Muscularis externa colonization by muscularis macrophages during 
development does not require enteric neural crest derived cells (ENCDC). 
ENCDC that become neurons and glia of the ENS first invade the bowel foregut at E9.5 
and then migrate through the bowel in a rostrocaudal direction towards the end of the colon 
(Burns & Thapar 2006). By E12.5 ENCDC reach mid-colon and by E14.5 the bowel is fully 
colonized by ENS precursors. MMs have been reported in the bowel as early as E15.5 
(Mikkelsen et al. 2004), but whether MMs are present in bowel prior to ENCDC colonization 
was not known.  Since adult enteric neurons produce CSF1 that supports MMs, we hypothesized 
that ENCDC should colonize fetal bowel before MM to create a hospitable environment.  To test 
this hypothesis, we used the neuronal marker TuJ1 to label enteric neurons.  TuJ1 identifies all 
regions of the bowel that contain ENCDC (Bergner et al. 2013; Lake et al. 2013; Schill et al. 
2015) since enteric neurons differentiate alongside migrating ENCDC. MMs were identified with 
the Iba1 antibody that is commonly employed for microglia staining in the central nervous 
system. We confirmed that Iba1 antibody labels all MMs in developing bowel by staining 
Cx3cr1-EGFP reporter mice that express EGFP in all bowel macrophages (Sup. Fig. 5.1). Iba1+ 
cells were present in the outer bowel wall in the region where muscle layers develop as early as 
E9.5 (Fig 5.1 A). At E12.5, muscularis macrophages are present throughout the small bowel 
alongside enteric neurons (Fig. 5.1B). MMs are also present in the distal colon, which is devoid 
of ENCDC at this age (Fig. 5.1C) suggesting that colonization of fetal bowel by MM does not 
require the ENS. To more definitively determine if the ENS is needed for MMs to colonize the 
bowel, we analyzed the muscularis externa of neonatal (P0) Ret knockout (Ret KO) mice that are 
completely missing  
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Figure 5.1 
 
Figure 5.1. Muscularis macrophages colonize the bowel with or without enteric neurons. 
(A) Iba1+ macrophages are present in the foregut as early as E9.5. (B) At E12.5, macrophages 
exist alongside the developing ENS in the small intestine and are also present in the colon, which 
is not yet colonized by ENCDC (C). (D-E) Distal small intestine of Ret knockout bowel is 
devoid of enteric neurons or other ENS lineage cells, but has well patterned muscularis 
macrophages present in normal abundance (F) (Student’s T-test p >0.05. N=4 mice per 
genotype). Scale bar in C applies to B-E. 
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enteric neurons and glia in the small bowel and colon. Surprisingly, Ret KO mice had normal 
numbers of MMs and the MM distribution in P0 bowel closely matched that in littermate 
controls where enteric neurons were visualized with HuC/D antibody (Fig. 5.1 D-F.)  
5.3.2 The developing bowel contains a non-neuronal source of the muscularis 
macrophage survival factor, CSF1.   
CSF1 is a key survival factor for many macrophage populations, including those in the 
muscularis externa. Mice lacking CSF1 (Op/Op mice) are completely devoid of MMs 
(Thuneberg 1999). It has been suggested in adults that enteric neurons are the primary source of 
CSF1 for MMs (Muller et al. 2014). However, our finding of well patterned MMs in mice 
lacking enteric neurons strongly suggests that alternative or additional sources of CSF1 exist, at 
least in neonatal and fetal mouse bowel. To determine whether enteric neurons are the main 
source of CSF1 in the developing bowel we used fluorescence activated cell sorting (FACS) to 
separate enteric nervous system cells from other components of the E12.5 mouse bowel wall.  
For this analysis we used a new mouse line (Ednrb-EGFP-L10a) in which all enteric neurons 
and precursors express EGFP fused to ribosomal protein L10A (Fig. 5.2 A-E). qRT-PCR on 
RNA isolated from EGFP-positive and EGFP-negative cells of the E12.5 bowel demonstrated 
successful enrichment for ENS expressed transcripts and depletion of non-ENS transcripts in the 
EGFP+ bowel cells (Fig. 5.2 F). We find that Csf1 is highly enriched in the non-ENS EGFP-
negative fraction (Fig. 5.2 G), consistent with a primarily non-ENCDC source of CSF1 during 
fetal development.  
5.3.3 Absence of enteric neurons does not affect the surface phenotype or 
baseline activation state of neonatal muscularis macrophages. 
 
 Enteric neurons appeared to be dispensable for the survival and patterning of muscularis 
macrophages, but it was unclear whether they were required for normal macrophage phenotype  
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Figure 5.2 
 
Figure 5.2. Csf1 is predominantly expressed in non-ENS cells of fetal bowel as shown by 
FACS sorting ENCDC from Ednrb-EGFP-L10a mice that express EGFP in all ENS 
precursors. 
(A-D) Immunohistochemistry for SOX10 and HuC/D, almost completely overlaps EGFP-L10A 
fluorescence in E12.5 small bowel of Ednrb-EGFP-L10a mice. 100% of SOX10 or HuC/D-
positive cells express EGFP-L10A. (D) Rare EGFP-L10A-positive cells are SOX10- and Hu 
C/D-negative (arrows). (E) Quantification of immunohistochemistry data (N=3 mice). (F) 
Analysis of mRNA levels for TuJ1, Sox10 and Ednrb (ENS lineage markers) and for Sma 
(expressed in smooth muscle) by qRT-PCR demonstrated that FACS sorting bowel cells from 
Ednrb-EGFP-L10a mice using EGFP-L10A fluorescence efficiently separated ENS precursors 
from other cells in the bowel wall.  (G) Csf1 is expressed at higher levels in non-ENS cells as 
compared to ENS cells in the E12.5 bowel wall based on qRT-PCR analysis (N=4 biological 
replicates for each gene). * p<0.01, Student’s T-test. 
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or function. To assess the baseline activation state, and thus the immunostimulatory potential of 
muscularis macrophages developing in the absence of enteric neurons, we analyzed MMs from 
control and Ret KO mice by flow cytometry. CD11b+F4/80+ muscularis macrophages were 
readily detectable (Fig. 5.3A) and were present at similar frequencies in both control and Ret KO 
mice (Fig. 5.3B), consistent with our immunohistochemistry data. As further confirmation of 
their macrophage identity, Ret KO CD11b+F4/80+ cells expressed equivalently high levels of 
CSF1R as control macrophages (Fig. 5.3C), suggesting these cells are equally poised to respond 
to the key survival factor CSF1. Interestingly, expression of the co-stimulatory molecules CD40 
and CD86, as well as major histocompatibility complex (MHC) class II, was unaltered in mice 
lacking enteric neurons (Fig 5.3D). Similar to control macrophages, Ret KO macrophages 
expressed these activation markers at relatively low levels, consistent with a non-activated 
phenotype. Of note, while MMs have previously been characterized as MHC IIhigh in adult mice 
(Muller et al. 2014), the low levels of MHC II seen in our study are likely a result of age-related 
differences, as MHC II is generally not expressed by MMs in neonatal mice (Mikkelsen et al. 
2004). Thus, our data demonstrate that muscularis macrophages developing in the absence of 
enteric neurons are phenotypically intact. Furthermore, enteric neurons are dispensable for 
establishing the resting phenotype of muscularis macrophages in neonatal mice. 
 
5.3.4 Muscularis macrophages from neonatal mice lacking enteric neurons did 
not differ from control mice in their activation by LPS stimulation.  
To determine if muscularis macrophages from mice without an ENS would manifest a 
different response from WT MMs when challenged with LPS, we dissected out P0 Ret KO or 
littermate control muscularis externa and cultured for 6 hours in the presence or absence of LPS. 
Following treatment, the tissue was assayed for expression of IL-6 and TNFα cytokines using  
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Figure 5.3 
 
Figure 5.3.  Absence of enteric neurons does not affect the surface phenotype or baseline 
activation state of muscularis macrophages. 
P0 bowel muscle layers from control and Ret KO mice were digested into single cell suspensions 
and analyzed for expression of surface markers by flow cytometry. (A) Representative flow 
cytometry plots pre-gated on live cells by forward and side scatter and exclusion of LIVE/DEAD 
dye. Numbers indicate the frequency of CD11b+F4/80+ macrophages among live cells. (B) 
Summary data showing macrophage frequencies among live cells. No statistically significant 
differences between control and Ret KO by Student’s t-test. (C) Representative histograms 
showing CSF1R expression on CD11b+F4/80+ macrophages compared to non-myeloid (CD11b-) 
cells. (D) Representative histograms comparing expression of CD40, CD86, and MHC Class II 
in control and Ret KO macrophages. No statistically significant differences between control and 
Ret KO by Student’s t-test.  Control N=4, Ret KO N=3 mice.   
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qRT-PCR and for secretion of these cytokines by ELISA. Similar to our observations at baseline, 
we find that the LPS response, as measured by increased expression of IL-6 and TNFα (Fig. 
5.4A-B) and increased secretion of IL-6 (Fig. 5.4 C), is unaltered in muscularis devoid of enteric 
neurons. TNFα protein levels were below the limit of detection in both Ret KO and control 
stimulated and un-stimulated samples.   
 
5.3.5 Maintenance of the muscularis macrophage population in the steady 
state adult bowel does not require CCR2-mediated monocyte recruitment 
from bone marrow.  
The presence of Iba1+ cells in the outer bowel wall mesenchyme as early as E9.5 
suggests that the macrophages interacting with the developing ENS are yolk-sac derived. Prior 
studies have shown that although bowel macrophages in newborn mice are of embryonic origin 
(Bain et al. 2014) the majority of colonic macrophages in adult and aged animals are replaced by 
bone-marrow derived cells in a CCR2-dependent process (Bain et al. 2014). Interestingly, we 
find this not to be the case for muscularis macrophages, which are present in normal numbers in 
aged 8-week old Ccr2 KO small intestine and colon (Fig. 5.5 A-F).  In contrast, macrophages in 
the submucosa of Ccr2 KO mice are modestly, but statistically significantly, reduced (Fig. 5.5 G-
I). This suggests that mechanisms governing the maintenance of muscularis macrophages differ 
from those applicable to macrophages elsewhere in the bowel.  
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Figure 5.4 
 
Figure 5.4. Muscularis macrophages from neonatal mice lacking enteric neurons do not 
differ from control mice in their activation by LPS stimulation.  
(A-C) LPS stimulation of muscularis externa from Ret knockout bowel induces similar increases 
in cellular IL-6 and TNFα cytokine mRNA levels (A-B) and in IL-6 protein secretion (C) as 
control animals. (qRT-PCR control N=6,  Ret KO N = 4 mice; ELISA N=4 mice from each 
group).   
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Figure 5.5
 
 
Figure 5.5. CCR2-mediated recruitment of bone marrow monocytes is not required for 
maintenance of muscularis macrophages.  
(A-F) Iba1+ muscularis macrophages in 8-week old Ccr2 KO mice are present in normal 
numbers in small intestine and colon compared to WT (p > 0.05, Student’s T-test) (G-I) In 
contrast, Iba1+ macrophages in the submucosa are modestly, but statistically significantly, 
reduced in 8-week old Ccr2 KO mice as compared to controls (p > 0.05, Student’s T-test)  (E-F). 
N=4 mice for each genotype. 
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5.4 Discussion 
 
5.4.1 ENCDC are dispensable for muscularis externa colonization and 
patterning by muscularis macrophages during development. 
Muscularis macrophages have been reported in the bowel as early as E15.5 (Mikkelsen et 
al. 2004), confirming their identity as true tissue resident macrophages. These cells are found 
along the entire length of the gastrointestinal tract both within and between the circular and 
longitudinal muscle layers. MMs residing in between the bowel layers, alongside enteric 
neurons, exhibit clear patterning, with cell bodies spaced at regular intervals and generally non-
overlapping processes (Phillips & Powley 2012; Muller et al. 2014; Gabanyi et al. 2016). MMs 
in the myenteric plexus plane are also frequently seen contacting myenteric neurons, as well as 
extrinsic neuronal projections (Muller et al. 2014; Phillips & Powley 2012; Cailotto et al. 2014; 
Matteoli et al. 2014). In adults it has been suggested that enteric neurons are a major source of 
the MM survival factor, CSF1. Unexpectedly we found that muscularis macrophage colonization 
of the bowel precedes colonization by enteric neurons, and Iba1-positive MMs are observed in 
the area of the developing muscle layers as early as E9.5. At E12.5 Iba1-positive MMs are 
observed throughout the colon, which does not yet contain ENCDC or enteric neurons. This time 
course suggests that developing MMs do not require enteric-neuron derived survival factors. 
Indeed, we find that Csf1 expression in the E12.5 bowel is highest in non-neuronal tissue. 
Consistent with this, Ret KO mice in which ENCDC fail to colonize the bowel have normal 
numbers of well-patterned MMs at birth. This suggests that enteric neurons are dispensable for 
the initial patterning of the muscularis externa by MMs. Several non-ENCDC cell types may 
serve as a local source of CSF1 in the developing bowel, including smooth muscle cells, 
interstitial cells of Cajal (ICC), epithelial cells, endothelial cells lining blood vessels, as well as 
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extrinsic sympathetic and parasympathetic nerve fibers terminating in the bowel. At E9.5 and 
E12.5 in the distal colon, many of these cells, including smooth muscle, ICC, and epithelium 
have yet to differentiate (de Santa Barbara et al. 2003; Young 2008; Garcia-Lopez et al. 2009), 
and extrinsic innervation is not yet present (Obermayr et al. 2013), suggesting that endothelial 
cells or undifferentiated mesenchyme is the most likely source of local CSF1 at this age. 
Alternatively, it is possible that a local source of CSF1 is not required, and circulating CSF1 in 
the embryo and fetus are sufficient to keep MMs alive. The aforementioned potential sources of 
CSF1 may also provide cues for establishing the regular patterning of MMs. Alternatively, MM 
patterning may be achieved in a cell-autonomous fashion, via homophilic repulsion mechanisms 
such as those regulating self-avoidance and tiling of neuronal cell bodies and processes in brain 
and retina (Hughes et al. 2013; Hattori et al. 2008). 
5.4.2 Development of neuro-immune interactions in the bowel muscularis 
externa. 
Multiple examples of neuronal modulation of muscularis macrophages have now been 
recorded. Notably, vagus nerve stimulation of cholinergic enteric neurons that are in close 
contact with MMs decreases the ATP-induced Ca2+ response in MMs and reduce muscularis 
externa inflammation in the context of post-operative ileus (POI) (Matteoli et al. 2014). This 
effect relies on α7nAChR cholinergic nicotinic receptors on immune cells and occurs 
independently of the spleen or T cells (Matteoli et al. 2014). An anti-inflammatory MM 
phenotype is also induced by sympathetic nor-epinephrine signaling in response to bacterial 
infection (Gabanyi et al. 2016). Signaling via β2AR beta-adrenergic receptors has been shown to 
alter gene expression in MMs, resulting in upregulation of tissue-protective genes such as Chi3l3 
(chitinase 3-like 3) and Arg1 (arginase 1). Whether intrinsic enteric neurons play a role in 
mediating this extrinsic sympathetic response remains unclear.  
126 
 
In light of these studies we hypothesized that MMs in Ret KO mice would be hyper-
activated either at baseline or in response to LPS since Ret KO mice are missing enteric neurons 
and have defects in extrinsic sympathetic innervation of the bowel. However, we were unable to 
detect phenotypic differences in MMs sorted from neonatal Ret KO muscularis externa, or 
differences in cytokine production in response to LPS-stimulation. The lack of a differential 
response to LPS in ex-vivo muscularis externa may highlight the requirement of intact extrinsic 
sympathetic and parasympathetic connections for neuronal modulation of MMs, as these 
connections are severed in both Ret KO and control ex-vivo preparations.  Alternatively, the 
unaltered in vivo baseline phenotype of MMs from Ret KOs may indicate that the mature neuro-
immune circuitry responsible for modulating MM activation is not yet in place at P0.  
Importantly, the ENS retains a significant amount of plasticity following birth. In rodents the 
proportion of cholinergic neurons increases until P36 (de Vries et al. 2010) and some enteric 
neurons do not exhibit mature dendritic and electrophysiological properties until adulthood 
(Foong et al. 2012). Various environmental signals, such as intraluminal lipid exposure have 
already been shown to impact post-natal enteric neuron plasticity (de Quelen et al. 2011) and 
may have important roles in modulating neuro-immune circuit development in the bowel. 
Bacterial exposure is another well-established environmental signal that governs some features 
of MM phenotype. Specifically, bacterial exposure is required for expression of MHCII by MMs, 
and MMs from neonatal and germ-free mice lack MHC II expression (Mikkelsen et al. 2004). 
Clarifying which aspects of MM maturation are neuronally mediated is an important task for 
future studies and will likely require ablation of the ENS at different post-natal time points.  
5.4.3 Developmental origin and maintenance of muscularis macrophages.  
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In most organs, tissue resident macrophages initially arise from embryonic yolk sac 
progenitors but over time are partially or completely replaced by progenitors from the fetal liver 
(Hoeffel & Ginhoux 2015). Two notable exceptions to this paradigm are microglia, which are the 
tissue resident macrophages of the brain, and bowel macrophages. Whereas, at steady state, 
microglia remain entirely yolk-sac derived throughout adulthood (Ginhoux et al. 2010), bowel 
macrophages are continuously replaced by circulating blood monocytes in a CCR2-dependent 
process (Bain et al. 2014), with very few embryonically-derived macrophages remaining in the 
bowel of aged mice (Bain et al. 2014). Muscularis macrophages, which make up a tiny 
percentage of total bowel macrophages (Mikkelsen et al. 2011) closely resemble microglia in 
their morphology and intimate interactions with neurons. Interestingly, we find that muscularis 
macrophage abundance in aged 8-week old Ccr2 KO mice remains comparable to WT, in 
contrast to the reduced number of submucosal macrophages seen in Ccr2 KOs. This suggests 
that mechanism of MM homeostasis differ profoundly from those regulating the majority of 
bowel macrophages. At the very least, steady state maintenance of MMs does not require CCR2. 
An intriguing possibility is that adult MMs represent an embryonically-derived (perhaps even a 
yolk-sac-derived) self-renewing macrophage population, similar to microglia.  This question 
could be directly addressed using lineage tracing of yolk sac and fetal liver macrophage 
progenitors in adult muscularis externa.  
 
 
 
 
 
 
128 
 
5.5 Supplemental Data 
 
Supplemental Figure 5.1 
 
Supplemental Figure 5.1. Iba1 effectively labels muscularis macrophages. 
(A-C) Immunohistochemistry for Iba1 and Cx3cr1-EGFP fluorescence in muscularis externa of 
Cx3cr1-EGFP reporter mice shows that almost all EGFP+ cells are Iba1+.  A small percentage 
of Iba+ cells are EGFP negative (arrows). (D) Quantitative analysis of Iba1+ and EGFP+ cell 
populations. N=3 mice. 
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Supplemental Figure 5.2 
 
Supplemental Figure 5.2. ENCDC-specific Ednrb-EGFP-L10a mouse. 
(A) Transgenic construct used to make ENCDC-specific Ednrb-EGFP-L10a mouse. pEdnrb, 
Endothelin receptor B promoter; EGFP-L10a, enhanced green fluorescent protein- ribosomal 
protein L10a fusion. (B) The EGFP-RPL10A fusion protein is expressed in the neural tube of 
developing transgenic mice at E9.5, E11.5, E13.5, and E14.5. (C)  EGFP fluorescence in the 
developing bowel at E13.5. Scale bar, 500 μm. (D) Transverse section of an Ednrb-EGFP-L10a 
mouse at E12.5 demonstrating EGFP expression in the neural tube. Scale bar, 20 μm. 
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Chapter 6: Conclusions and Future 
Directions 
 
6.1 HGF/MET Signaling in the ENS 
The enteric nervous system (ENS) has many neuronal subtypes that coordinate and 
control intestinal activity.  Trophic factors that support these neuron types and enhance neurite 
growth after fetal development are not well understood.  We show that Met is expressed broadly 
in the ENS during early development but becomes restricted to a subset of CGRP –positive 
intrinsic primary afferent neurons (IPANs) in adult animals. Met cKO mice missing functional 
MET protein in their ENS have shorter neurites in Met-expressing neurons and display an 
abnormal peristaltic response triggered by mucosal deformation.  Met cKO mice also have 
increased susceptibility to DSS induced bowel injury and reduced levels of bowel epithelial 
proliferation. These observations raise a number of additional questions.   
We need to define the interplay between MET and RET signaling in the developing ENS. 
Low levels of GDNF/RET signaling in vitro induces Met transcription, but unlike in the kidney, 
this effect did not rely on Etv4/Etv5 signaling. Despite this initial induction, the MET and RET 
receptor tyrosine kinases become restricted to non-overlapping neuronal populations by 
adulthood. Which neuronal populations retain Ret expression in the adult ENS is currently 
unknown. The mechanisms and significance of this restriction are also unknown and warrant 
further investigation.  
 Perhaps the largest number of questions arising from this work pertain to how HGF/MET 
signaling in a set of IPANs regulates epithelial response to mucosal injury. Although several 
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mechanisms could underlie this observation, one intriguing hypothesis involves impaired CGRP 
signaling from Met-positive IPANs onto macrophages in the bowel. CGRP has previously been 
shown to regulate gene expression in bowel macrophages (Baliu-Piqu et al. 2014; Glowka et al. 
2015), and bowel macrophages are known to promote survival and proliferation of epithelial 
progenitor cells during colonic wound healing (Lundgren et al. 2011). It would be interesting to 
directly test whether CGRP treatment of specific bowel macrophage populations (i.e. muscularis 
macrophages vs. lamina propria macrophages) or activation of Met-positive IPANs can trigger 
epithelial proliferation.  
Overall, our studies on HGF/MET signaling in the ENS may be relevant for 
understanding and treating intestinal motility disorders and also suggest that enhancing the 
activity of MET expressing CGRP neurons might be a useful strategy to reduce inflammatory 
bowel injury. 
 
6.2 Axon pathfinding in the ENS 
Although much progress has been made in understanding early events in ENS 
development, almost nothing is known about how axons of enteric neurons navigate to their 
targets to generate functional neural circuits. Defects in these processes may contribute to the 
pathophysiology of various enteric neuropathies such as chronic idiopathic intestinal pseudo-
obstruction (CIIP) and certain cases of irritable bowel syndrome (IBS) (Di Nardo et al. 2008; 
Faure et al. 1999). Furthermore, understanding mechanisms regulating enteric neuron 
connectivity will be crucial for the generation of effective regenerative stem cell therapies that 
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might be used to treat not only rare congenital defects, but also common acquired enteric 
neuropathies such as those associated with Parkinson’s disease and diabetes (Rivera et al. 2011). 
 We identified several genes encoding classical axon guidance receptors that are enriched 
in the developing ENS, with Plexin A4 exhibiting the greatest enrichment. Although the ENS of 
Plexin A4 knockout mice appears grossly normal, it is possible that these mice harbor subtle 
defects in neurite patterning that cannot be detected with broad staining methods. 
Characterization of the ENS of these mice would be greatly aided by a reliable antibody to 
Plexin A4 that would allow us to determine which enteric neuron subtypes (if any) produce 
Plexin A4. Additionally, sparse genetic labeling of Plexin-A4 expressing neurons would allow us 
to definitively identify any defects in axonal trajectories of these neurons in Plexin A4 KO mice.   
While Plexin A4 KOs have no defects in peristalsis, there are a number of other motility 
patterns, such as those involved in mixing zand segmentation of luminal content (Furness 2008) 
that could be affected in these animals. Alternatively, Plexin A4 may be expressed in neurons 
that are part of the secretory or vasodilatory reflexes in the bowel. More thorough functional 
testing may reveal gastrointestinal disturbances in Plexin A4 KO mice.  
Several cell adhesion molecules with known roles in regulating axon trajectories were 
also identified as enriched in the developing ENS. These include MDGA2, NrCAM, NCAM1, 
NCAM2, and L1CAM. Enteric neurons are clustered into ganglia which serve as basic units of 
connectivity that are repeated around and along the length of the bowel. Given this arrangement, 
long range axon guidance cues may not be the best means of establishing connectivity within a 
plexus. Homophilic or heterophilic interactions via cell adhesion molecules on adjacent axons 
may represent another mechanism of axon targeting within the ENS. 
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6.3 Muscularis Macrophage Development and the ENS 
 Understanding neuro-immune interactions with bowel macrophages may provide insight 
both into developmental bowel disorders, such as Hirschsprung’s associated enterocolitis 
(HAEC), as well as into adult inflammatory bowel disease. Our work on muscularis 
macrophages shows that this population of macrophages colonizes the bowel before the arrival 
of ENS precursors, and that enteric neurons are dispensable for muscularis macrophage survival 
and patterning of the bowel. Additionally, the absence of enteric neurons in the neonatal bowel 
does not alter the surface phenotype of muscularis macrophages or their response to LPS. 
Finally, we also demonstrate that maintenance of the muscularis macrophage population does not 
require CCR2-mediated recruitment of monocytes, as is the case for mucosal and lamina propria 
macrophages.  
 Further investigation is required to determine the time course during which enteric 
neurons begin to influence muscularis macrophage phenotype and activation status. This can be 
accomplished using conditional Ret KO mice that are only missing RET in neural crest 
derivatives, to avoid neonatal lethality caused by kidney agenesis in germline Ret KO mice.  
Additionally, the effect of individual neurotransmitters on muscularis macrophage activation can 
be assessed systematically.   
 Our findings that muscularis macrophage abundance is not altered in aged Ccr2 KO mice 
does not rule out the possibility that adult muscularis macrophages are still bone marrow derived 
but are recruited to the muscularis externa in a CCR2-independent manner. To definitively assess 
whether adult muscularis macrophages are primarily derived from bone marrow, fetal liver, or 
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yolk sac, we could perform lineage tracing experiments using Cx3cr1CreER mice bred to 
R26tdTomato reporter mice. A single tamoxifen treatment at E8.5 would irreversibly label 
macrophages arising from CX3CR1+ yolk-sac progenitors, but not from fetal liver or adult bone 
marrow.  This strategy has been used to successfully label microglia but not peripheral 
monocytes and macrophages (Parkhurst et al. 2013; Ginhoux et al. 2010). If muscularis 
macrophages are constantly replaced by circulating bone marrow derived monocytes, the 
percentage of fluorescently labeled muscularis macrophages should decrease with age, as is the 
case for lamina propria macrophages (Bain et al. 2014). However, if muscularis macrophages 
resemble microglia, in that they are yolk sac derived cells capable of self-renewal in situ, the 
percentage of fluorescently labeled muscularis macrophages would remain comparable at 
different ages.   
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